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In MCF-7 breast tumor cells, ionizing radiation promoted autophagy that was cytoprotective;  
pharmacological or genetic interference with autophagy induced by radiation resulted in growth 
suppression and/or cell killing (primarily by apoptosis).  The hormonally active form of vitamin 
D, 1,25D3, also promoted autophagy in irradiated MCF-7 cells, sensitized the cells to radiation 
and suppressed the proliferative recovery that occurs after radiation alone. 1,25D3 also enhanced 
radiosensitivity and promoted autophagy in MCF7 cells that overexpress Her-2/neu  as well as in 
p53 mutant Hs578t breast tumor cells. In contrast, 1,25D3 failed to alter radiosensitivity or 
promote autophagy in the BT474 breast tumor cell line with low-level expression of the vitamin 
D receptor.  Enhancement of MCF-7 cell sensitivity to radiation by 1,25D3 was not attenuated by 
either a pharmacological or genetic block to autophagy; this was due largely to the promotion of 
apoptosis via the suppression of protective autophagy that occurs in response to radiation alone. 
Moreover, pharmacological blockade of autophagy did not sensitize noncancerous MCF10a cells 
to radiation; conversely, 4T1 mouse mammary tumors were highly sensitive to pharmacological 
inhibition of autophagy, suggesting selective radiosensitization against cancer cell lines.  The 
current studies are consistent with the premise that while autophagy mediates a cytoprotective 
function in irradiated breast tumor cells, promotion of autophagy can also confer radiosensitivity 
by vitamin D (1,25D3).   In addition, this work highlights the technical challenge of establishing 
the potential cytotoxic function of autophagy in an experimental system where the cytoprotective 
function may be concurrently expressed. 
 
 
1 
CHAPTER ONE 
 
Introduction and Review of the Literature 
 
 
1.1 Cancer 
Normal cells grow, divide, and die in an orderly fashion.  Cancer cells continue to 
grow indefinitely and can also invade other tissues.  Cancers may be caused by a number 
of environmental factors such as toxins and irradiation and/or may also arise because of 
inherited mutations in the DNA; however, the cause of many cancers remains unknown 
(American Cancer Society, 2010).   
Solid tumors can develop in almost any organ or tissue, while some cancers, like 
leukemia, that involve the blood and blood-forming organs, circulate through other tissues 
where they can deposit and grow (American Cancer Society, 2010).   
Cancer is the second most common cause of death in the US, exceeded only by 
heart disease.  In 2010, approximately 569,490 Americans were expected to die of cancer, 
more than 1,500 people a day.  Half of all men and one-third of all women in the US will 
develop cancer during their lifetimes.  While these numbers remain very high, early 
detection and diagnosis, combined with increasing numbers of treatment options, have 
improved the survival rates of most cancers (American Cancer Society, 2010).    
 
1.2 Breast Cancer and Treatment 
Besides skin cancer, breast cancer is the most commonly diagnosed cancer among 
U.S. women.  Nearly 1 in 8 women in the United States (12%) will develop invasive breast 
 2 
cancer over the course of their lifetime.  In 2010, an estimated 207,090 new cases of 
invasive breast cancer were expected to be diagnosed in women in the U.S., along with 
54,010 new cases of non-invasive breast cancer; of these women, approximately 39,840 
were expected to die.  About 1,970 new cases of invasive breast cancer were expected to 
be diagnosed in men in 2010. Less than 1% of all new breast cancer cases occur in men 
(breastcancer.org, 2011).   
There are a variety of treatments for breast cancer.  Treatment will depend on the 
type of breast cancer and whether it has metastasized.  Treatments can include surgery, 
radiation, chemotherapy, and hormonal therapy, alone and in various combinations.  Breast 
cancer can be treated locally through surgical resection of only the tumor (lumpectomy) or 
the entire breast (mastectomy) and the tumor may be irradiated with ionizing radiation; in 
addition, various classes of chemotherapeutic drugs and hormone therapy are commonly 
used in combination with surgery or radiation.  Systemic therapy that is administered 
before removal of the tumor is considered neoadjuvant chemotherapy. The most common 
reason for neoadjuvant therapy is to reduce the size of the tumor (debulking) so as to 
facilitate more effective surgery. The administration of chemotherapy following surgery is 
known as adjuvant therapy and is directed at killing cancer cells that may have been 
missed in the resection of the tumor.  Commonly used chemotherapeutic agents for the 
treatment of breast cancer are cyclophosphamide, methotrexate, 5-fluorouracil, 
doxorubicin, epirubicin, docetaxel, and paclitaxel; trastuzumab may be given as hormonal 
therapy for HER2/neu positive tumors.  The toxicity of these drugs is a major limiting 
factor in their use.  Furthermore, while chemotherapy and radiation treatment may be 
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initially effective at suppressing breast cancer growth, disease recurrence and tumor 
metastasis are major clinical problems (American Cancer Society, 2010).    
 
1.3 Radiation Therapy  
 About half of all cancer patients receive some type of radiation therapy sometime 
during the course of their treatment (National Cancer Institute at the National Institutes of 
Health, 2011).  When radiation therapy is chosen, an external beam irradiator can be used 
to deliver focused irradiation to the breast tumor; internal radiation, or brachytherapy, may 
also be employed, where small pellets of radioactive material are implanted at the site of 
the tumor.  The targeted area may include the whole breast but may also target the chest 
wall and the underarm area, depending on the location of the tumor.  The total amount of 
radiation patients receive is measured in units called Gray (Gy) (American Cancer Society, 
2010).    
Like chemotherapy, radiation therapy is toxic not only to the tumor, but to 
surrounding healthy cells.  To reduce this toxicity, patients receive smaller, fractionated 
doses of radiation; fractionated radiation also serves to increase the likelihood that cancer 
cells are exposed to radiation at the points in the cell cycle when they are most vulnerable 
to DNA damage (discussed later).   Patients who receive most types of external-beam 
radiation therapy may receive one dose (a single fraction), or multiple doses of radiation a 
day, up to 5 days a week for several weeks.  Patients generally receive a total of between 
40Gy in 2Gy doses. (American Cancer Society, 2010).    
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 Radiation has been shown to induce many types of DNA lesions that have the 
potential for cell killing; these can include both single and double stranded breaks in DNA.  
Radiation can also induce lesions via free radical-induced oxidation of DNA bases (Olive, 
1998; Povirk and Steighner, 1989).  Ionizing radiation (IR) is thought to produce about 
1000 single-strand breaks and 25-40 double-strand breaks per diploid cell per gray 
administered.  The cell death induced by IR is most likely the result of lack of repair or 
misrepair of complex lesions in DNA (Olive, 1998).   
Ionizing radiation causes atoms and molecules to become ionized or excited. These 
excitations and ionizations can: produce free radicals, break chemical bonds, produce new 
chemical bonds and cross-linkage between macromolecules, and damage molecules that 
regulate vital cell processes (e.g. DNA, RNA, proteins)(Princeton University, 2010). The 
cell can undergo a number of responses to IR including: DNA repair, transcriptional 
responses, DNA damage checkpoint arrest, and apoptosis (Figure 1.1) (Sancar et al., 
2004).  When DNA damage is sensed by the cell, depending on the type of damage 
induced, a number of proteins are recruited to the site and are activated.  This may result in 
a temporary arrest in which the cell will attempt to repair itself, or senescence (discussed in 
more detail in the following section).  If the DNA damage can be repaired, it is thought 
that the cell is then allowed to reenter the cell cycle and resume proliferation.  If the IR-
induced DNA damage is too great or the repair mechanisms have been compromised, the 
cell may fail in its attempt to repair the lesion, consequently leading to cell death.  It is also 
important to mention that DNA lesions induced by IR may also lead to aberrations, 
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allowing for unregulated cell division which can lead to cancer itself (Olive, 1998; Sancar 
et al., 2004). 
1.4 Radiation-induced Cell Cycle Arrest 
As previously stated, there are a number of proteins involved when DNA damage is 
sensed by the cell.  Central to the cell’s response to radiation is p53.  The p53 gene and the 
protein it encodes for are known as the “guardian of the genome” and can inhibit 
tumorigenesis via initiation of cell cycle arrest after DNA damage to allow for repair.  
Levels of p53 are normally kept low within the cell via association with mdm2; following 
damage, levels of p53 rise dramatically through post-translational modification.  Moreover, 
ATM phosphorylates p53, displacing mdm2, allowing for p53 stabilization and activation.  
Activation of p53 can allow for growth arrest or cell death depending on the downstream 
targets activated.  p53 is the most frequently mutated gene in human cancers with the 
incidence rate over 50%.  Defects in p53 may lead to the inability to arrest cells following 
DNA damage, leading to genomic instability and possibly carcinogenesis (Brady and 
Attardi, 2010; Lakin and Jackson, 1999; Olive, 1998).  
The process of DNA replication and cell division are tightly regulated to ensure 
proper cell growth, transit through the cell cycle, and prevent the replication of damaged 
DNA.  Progression through the cell cycle is regulated by cyclins, cyclin-dependant kinases 
(CDKs) and CDK inhibitors (CKIs).  Activity of cyclins and CDKs allows for the cell to 
pass certain “checkpoints” in the cell cycle; CKIs prevent progression through the cell 
cycle promoting growth arrest (Deshpande et al., 2005).  (Figure 1.2) 
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 Many types of cellular stress can lead to growth arrest.  Cell cycle progression can 
be halted through growth factor withdrawal, contact inhibition, and radiation or 
chemotherapy-induced DNA damage.  DNA damaging agents, such as radiation, can arrest 
cells in either the G1 or G2 phase through” checkpoints” at the transition between G1/S and 
G2/M.  Cells may also exit the cell cycle and enter G0, or quiescence.  Although many cells 
in the G0 phase may die, not all cells that enter the G0 phase are destined to die; this is 
often simply a consequence of the cell's lacking any stimulation to re-enter in the cell 
cycle.  Cellular senescence is distinct from quiescence because it is a state that occurs in 
response to DNA damage or degradation that would make a cell's progeny nonviable and is 
generally considered irreversible; however, there is some evidence suggesting senescence 
is not entirely irreversible (Chandeck and Mooi, 2010; Gewirtz et al., 2008; Lakin and 
Jackson, 1999; Sancar et al., 2004; Wang et al., 2011) 
 The G1/S checkpoint prevents cells from entering the S phase in the presence of 
DNA damage by inhibiting the initiation of replication.  Similarly, the G2/M checkpoint 
prevents cells from undergoing mitosis in the presence of DNA damage.  If the DNA 
damage is double-strand breaks, such as those caused by ionizing radiation or 
radiomimetic agents, ATM or ATR is activated and phosphorylates many target molecules, 
notably p53, Chk1 and Chk2.  Although the G1/S and the G2/M checkpoints are distinct, 
the damage sensor molecules that activate the various checkpoints appear to either be 
shared or to play a primary sensor role in one pathway and a back-up role in the other 
(Sancar et al., 2004). 
 7 
 Senescence is the phenomenon by which normal diploid cells lose the ability to 
divide; this can be due to the normal aging process, or as a response to stress or DNA 
damage.  Senescence is typically associated with activation of p53 and p21 with 
subsequent inactivation of Rb and a pronounced G1 arrest.  p16, a CKI, can also be 
activated in senescent cells.  The senescent cells are characterized by flattened and 
enlarged morphology, increased granularity, and expression of pH 6-dependant β-
galactosidase activity (Dimri et al., 1995; Zhang, 2007).  
 
1.5 Apoptosis 
 Apoptosis, or programmed cell death I, occurs normally during development and 
aging and as a homeostatic mechanism to maintain cell populations in tissues.  Apoptosis 
can also occur as a defense mechanism when cells are damaged by disease or harmful 
agents.  Although there are a wide variety of apoptotic stimuli, not all cells will necessarily 
die in response to the same stimulus.  Irradiation, or drugs used for cancer chemotherapy 
result in DNA damage, in some cells, this can lead to apoptotic death while other cells may 
remain unaffected or even stimulated to grow (Elmore, 2007).  
First discovered by Carl Vogt in 1842, and named in 1972 by Kerr,Wyllie, and 
Currie, apoptosis is a morphologically distinct form of cell death, characterized by cell 
shrinkage, chromatin condensation, plasma membrane blebbing, and DNA 
fragmentation(Elmore, 2007; Khan, 2010).  Induction of apoptosis can be mediated 
through extrinsic or intrinsic machinery.   
 8 
The extrinsic pathway is also known as receptor mediated apoptosis because this pathway 
relies upon the interaction of specific death receptors with their corresponding ligands 
(Figure 1.3).   These receptors are located on the cell surface and induce apoptosis via 
 9 
 
 
Figure 1.1 DNA damage response reactions in mammalian cells. These responses (DNA repair, 
apoptosis, senescence, autophagy, and necrosis) may function independently, but frequently a 
protein primarily involved in one response may participate in other responses.   
 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Components of DNA damage checkpoints in human cells. DNA damage 
is detected by sensors that signal to transducers, in turn, activating or inactivating other 
proteins that directly participate in inhibiting the G1/S transition, S-phase progression, 
or the G2/M transition.  
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signaling cascades initiated by their intracellular domains; the receptors are of the TNF 
receptor subfamily and consist of cysteine rich motifs.  The most commonly extrinsic-
associated receptors are Fas (APO/CD95) and TNFR (Khan, 2010); together with their 
ligands, Fas L and TNF, respectively, lead to the cleavage of procaspase 8 to active 
caspase 8, in turn cleaving procaspase 3 (or procaspases 6 or 7 into active caspase 6 or 7) 
into the active executioner caspase 3 which is essential for certain processes associated 
with the dismantling of the cell and the formation of apoptotic bodies, resulting in DNA 
fragmentation, degradation of cytoskeletal and nuclear proteins, cross-linking of proteins, 
expression of ligands for phagocytic cell receptors and finally uptake by phagocytic cells 
(Elmore, 2007; Khan, 2010).   
For the intrinsic pathway, also known as the mitochondrial pathway, signals 
typically originate inside the cell, but can also be activated via crosstalk with the extrinsic 
pathway.  Signaling for the intrinsic pathway may arise from various stimuli such as DNA 
damage, aberrations in the cell cycle, growth factor withdrawal, hypoxia, and cytotoxic 
drugs; these stimuli can alter the inner mitochondrial membrane through interactions of the 
pro-apoptotic Bcl-2 proteins Bax and/or Bak, resulting in the permeabilization of the 
mitochondrial membrane (Figure 1.3).  Loss of the mitochondrial transmembrane potential 
allows for the translocation of cytochrome c and the pro-apoptotic protein 
SMAC/DIABLO from the intermembrane space of the mitochondria into the cytosol.  
Cytochrome c binds the adaptor apoptotic protease activating factor-1 (Apaf-1), forming a 
large multiprotein structure known as the apoptosome.  The apoptosome then mediates the 
 12 
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cleavage and activation of procaspase 9 into caspase 9, which in turn activates the 
downstream effector caspases 3, 6, and/or 7 (Ashkenazi, 2008; Bao and Shi, 2007; Elmore, 
2007; Khan, 2010). 
  
1.6 Autophagy 
 Autophagy, or programmed cell death II, is a catabolic or “self-eating” process 
involving the degradation of a cell's own components through the lysosome.  It is a tightly-
regulated process that plays an important part in cell growth, development, and 
homeostasis, helping to maintain a balance between the synthesis, degradation, and 
subsequent recycling of cellular products. Additionally, it is a major mechanism by which 
a starving cell can reallocate nutrients from unnecessary processes to more-essential 
processes for survival.  Autophagy may help to prevent or halt the progression of some 
diseases such as some types of neurodegeneration and cancer, and play a protective role 
against infection by intracellular pathogens; conversely, in some situations, it may actually 
contribute to the development of a disease.  Moreover, autophagy can be cytoprotective or 
cytotoxic; it is currently not well understood as to what may be involved in the autophagic 
transformation between death and survival (Klionsky et al., 2008; Mizushima et al., 1998; 
Mizushima and Klionsky, 2007; Mizushima et al., 2008). 
 Nutrient starvation, growth factor deprivation, endoplasmic reticulum (ER) stress, 
infection, toxic compounds, and radiation can all initiate autophagy.  Signaling cascades 
involved in the initiation are mainly contributed to the ER stress and mammalian target of 
rapamycin (mTOR) pathways (discussed later); additionally, there may also be crosstalk 
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between the other growth arrest and cell death pathways.  Autophagy occurs at a basal 
level in most or all cells; as a starvation response, autophagy is subject to control by a 
range of nutrients including amino acids and certain hormones such as insulin. These 
receptors in turn activate downstream effectors such as the class I phosphatidylinositol 3-
kinase, and Akt/protein kinase B, resulting in the eventual activation of mTOR kinase, one 
of the primary negative regulators of autophagy; however, downstream effectors of mTOR 
are largely unknown.  In contrast, nutrient depletion results in mTOR inhibition and 
activation of autophagy.  The induction process also requires a class III 
phosphatidylinositol 3-kinase (Mizushima and Klionsky, 2007).  
 During autophagy, the cytoplasm and cytoplasmic organelles are nonspecifically 
sequestered within a double-membrane cytosolic vesicle, an autophagosome, which then 
fuses with the lysosome, forming an autophagolysosome; sequestered components are then 
degraded via lysosomal hydrolases (Figure 1.4).  The degraded products can be reused for 
anabolic or catabolic reactions in the cell.  The autophagic degradation process is unique in 
that it can degrade whole organelles and is not limited sterically.  Furthermore, autophagy 
is generally considered a nonselective degradation system; however, there are many 
examples of selective autophagy.  In mammals, p62/SQSTM1 (p62) seems to be a 
selective substrate for autophagy that is mediated by microtubule-associated protein 1 light 
chain 3 (LC3) binding (Mizushima and Klionsky, 2007).   
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 Autophagosome formation involves expansion of the cell membrane.  While the 
process is still not fully understood, autophagy genes, and their corresponding proteins 
(ATG) serve to direct the membrane into a three-dimensional double membrane sphere 
through two interconnected conjugation processes (Figure 1.4).  ATG8 (LC3 in mammals) 
and ATG12 are ubiquitin-like proteins, however are not ubiquitin homologues.  LC3-I is 
processed by ATG4, exposing a glycine, whereas ATG12 is synthesized with the glycine; 
both proteins are activated by ATG7.  The activated intermediates are transferred to 
ubiquitin-conjugating analogues, ATG3 and ATG10, respectively.  LC3-I is then 
covalently attached to phosphatidylethanolamine converting it to LC3-II, causing it to 
become membrane-associated, whereas ATG12 covalently modifies ATG5 via an 
isopeptide linkage to an internal lysine.  LC3 is the only ATG protein that remains 
associated with the completed autophagosome in mammalian cells, and thus serves as one 
of the few markers for autophagy.  ATG5 binds ATG16 noncovalently, and the 
tetramerization of ATG16 results in the formation of a larger complex (Mizushima and 
Klionsky, 2007; Yang et al., 2005).   
 
 
1.7 mTOR and Autophagy  
 As previously stated, there are a number of signaling complexes and pathways 
involved in autophagy. One key contributor is mTOR, a serine/threonine kinase involved 
in the majority of regulatory pathways that control the response to variations in nutrient 
conditions and metabolism. mTOR acts as a gate-keeper in autophagy and appears to 
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directly and/or indirectly affect ATG proteins, resulting in interference with the formation 
of autophagosomes.  mTOR is active under favorable growth conditions, and promotes 
ribosome biogenesis, initiation of translation, and nutrient import.  Under mTOR-
inactivating conditions, i.e., nutrient deprivation, cells undergo autophagy (Diaz-Troya et 
al., 2008; Yang et al., 2005).   
 When nutrition is sufficient, mTOR is activated (Figure 1.5).  4E-BP1 is an 
inhibitor of translation and can be directly phosphorylated by mTOR. After 
phosphorylation, 4E-BP1 will dissociate from eukaryotic initiation factor 4E (eIF4E); free 
eIF4E binds RNA and promotes the progression of translation.  Likewise, p70S6 kinase 
(S6K) is activated by mTOR; S6K is a protein kinase and its phosphorylation upregulates 
translation.  Moreover, phosphorylation of 4E-BP1 and S6K requires the presence of 
amino acids, which are the final products of autophagic protein degradation, thus acting as 
negative feedback regulators for the process. Conversely, the amino acid/TOR signaling 
pathway can be inhibited by the AMP-dependent protein kinase (AMPK) (Diaz-Troya et 
al., 2008; Yang et al., 2005).   
 
1.8 ER-stress and Autophagy 
 
The endoplasmic reticulum (ER) is a crucial site for folding and quality control of 
proteins destined to the cell surface and intracellular organelles.  Pathogen infection, 
nutrient deprivation inflammation, alterations in ER lumenal Ca2+ or redox status, genetic 
mutation, toxic chemicals, etc., can interfere with ER homeostasis, disrupt protein folding, 
 18 
 
 
Figure 1.5: mTOR signaling overview.  mTOR, a serine/threonine kinase, acts as a gate-keeper in 
autophagy and appears to directly and/or indirectly affect ATG proteins, resulting in interference with 
the formation of autophagosomes.  mTOR is active under favorable growth conditions, and promotes 
ribosome biogenesis, initiation of translation, and nutrient import.  Under mTOR-inactivating 
conditions, i.e., nutrient deprivation, cells undergo autophagy. 
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Figure 1.6: Overview of ER stress pathway: The UPR is regulated through three ER-
localized transmembrane proteins (PERK, IRE1, and ATF6) that sense the accumulation 
of unfolded proteins.   ER stress-induced autophagy may serve an important role in the 
clearance of aggregated or misfolded proteins in the ER that cannot be degraded by ER-
associated proteasomal degradation.   
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and cause the accumulation of misfolded proteins.  These conditions are collectively 
referred to as “ER stress”, and can ultimately activate an autophagic response.  Autophagy 
serves an important role in the clearance of aggregated or misfolded proteins.  It is thought 
that ER stress-induced autophagy evolved as a mechanism to degrade misfolded proteins 
in the ER that cannot be degraded by ER-associated proteasomal degradation (Sakaki and 
Kaufman, 2008).   
Cells constantly monitor protein folding in the ER and can adjust protein synthesis, 
degradation, and folding capacity to prevent the accumulation of misfolded proteins via 
signals contributed to the unfolded protein response (UPR) pathway (Figure 1.6).  The 
UPR is regulated through three ER-localized transmembrane proteins (PERK, IRE1, and 
ATF6) that sense the accumulation of these unfolded proteins (Sakaki and Kaufman, 
2008).   
PERK phosphorylates eukaryotic translation initiation factor 2 on the alpha subunit 
(eIF2α) to attenuate mRNA translation initiation.  Conversely, eIF2α phosphorylation 
increases translation of Atf4 mRNA which encodes a transcription factor required to 
activate most of the UPR-induced genes.  IRE1 is a bifunctional protein kinase and 
endoribonuclease that cleaves Xbp1 mRNA to generate a translational frame shift that 
produces a potent basic leucine zipper (bZIP)-containing transcription factor.  
Correspondingly, ATF6 contains a bZIP transcription factor domain in its cytosolic amino 
terminus. Upon activation of the UPR, ATF6 translocates to the Golgi complex where it is 
cleaved and then trafficked to the nucleus to activate transcription of genes encoding 
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protein chaperones and machinery for ER-associated protein degradation (Sakaki and 
Kaufman, 2008).   
 
1.9 Vitamin D 
 Vitamin D is a steroid hormone, long associated with calcium homeostasis, but has 
also been shown to produce strong effects on cell growth, differentiation, and survival 
(Van Leeuwen and Pols, 2005).  Vitamin D (no subscript) can refer to two major 
physiologically relevant forms of which are vitamin D2 (ergocalciferol) and vitamin D3 
(cholecalciferol).  Vitamin D2 is a derivative of ergosterol, a membrane sterol, and is 
produced by some organisms of phytoplankton, invertebrates, and fungi in response to UV 
irradiation; D2 is not produced by land plants or vertebrates (Mayo Clinic).  All future 
mentions of vitamin D will refer to vitamin D3.  Vitamin D3 is synthesized through a 
multistep process, starting in the skin (Figure 1.7) in which UV rays convert 7-  
dehydrocholesterol to pre-vitamin D; the body’s internal temperature then allows for 
spontaneous structural conversion to the more favorable conformation: vitamin D3 
(cholecalciferol).  Vitamin D3 is further modified in the liver, predominantly through by 
CYP2R1, to 25α hydroxyl vitamin D3 (25D3), then 1α hydroxylated in the kidney via  
CYP27B1 to the hormonally active form, 1,25 dihydroxy vitamin D3 (1,25D3).  Vitamin 
D’s action is limited by its catabolism, primarily by 24-hydroxylase activity via CYP24A1; 
converting 1,25D3 to 1,24,25 trihydroxylase vitamin D3, which is then further metabolized 
to excreted products such as calcitrolic acid.  Vitamin D compounds are transported  
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Figure 1.7: Vitamin D pathway. In the skin, 7-
dehydrocholesterol, a derivative of cholesterol, is 
converted by UV light to pre-vitamin D.  Pre-
vitamin D3 spontaneously isomerizes to vitamin D3 
which is hydroxylated in the liver at position to form 
25 α Vitamin D3 via 25-hydroxylase.  Once made, this 
product is released into the plasma, where it is bound 
to an α-globulin, vitamin D binding protein (DBP).  
25 α Vitamin D3 can then travel to the kidney or other 
tissues where it is hydroxylated at the 1-α position to 
form 1,25-dihydroxy vitamin D.  This product is a 
potent ligand of the vitamin D receptor (VDR), which 
mediates most of the physiological actions of the 
vitamin. 
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through the body in conjunction with its specific binding partner, the vitamin D binding 
protein (DBP) (Trump et al., 2010). 
 
1.10 Vitamin D Receptor 
 The foremost pathway through which vitamin D mediates its biologic effects is 
through binding to its specific receptor, the vitamin D receptor (VDR).  Vitamin D bound 
to VDR can form homodimers or heterodimerize with the retinoid X receptor (RXR) and 
its ligand (9 cis-retinoic acid)  (Carlberg et al., 2005; Nishikawa et al., 1995; Trump et al., 
2010).  These dimers occupy specific binding sites on DNA (vitamin D response elements 
or VDREs). In conjunction with other transcription factors, these complexes induce 
transcription of vitamin D responsive genes (Evans, 1988). 
Among the many genes that are transcriptionally activated by vitamin D are 
CYP24A1, and CDKN1A (encoding p21Waf1/Cip1), the growth arrest and DNA-damage-
inducible gene, GADD45 gene; the parathyroid hormone gene (PTH) is repressed by 
calcitriol(Silver and Naveh-Many, 2005).  Vitamin D-mediated repression or activation of 
many protooncogenes or tumor suppressor genes has been observed in both normal and 
cancerous cells (Trump et al., 2010). 
 
1.11 Vitamin D and Cancer 
 Recent evidence supports that the VDR is not limited to cells and tissues involved 
in regulation of calcium and bone metabolism but is also present in a wide variety of cells 
and tissues including cancer cells of various origins.  This had led to a wide range of 
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studies on the role of vitamin D in tumor development, regulation, and treatment as well as 
the development of potent synthetic vitamin D analogs(Van Leeuwen and Pols, 2005).   
Moreover, there are significant data which indicate antitumor effects of vitamin D 
compounds in preclinical settings.  Vitamin D compounds have been shown to inhibit 
growth and even kill cancer cells in vitro and in vivo and more recently have demonstrated 
their potential to potentiate the antitumor activity of a number of traditional cancer 
therapeutics (Trump et al., 2010).  Additionally, clinical data supports the hypothesis that 
individuals with lower serum levels of vitamin D have a higher risk of a number of 
cancers.   Unfortunately, very limited data are available to indicate whether or not vitamin 
D supplementation can reduce the risk of such cancers (Trump et al., 2010). 
 
1.12 Vitamin D-induced growth arrest and cell death 
Key mediators in vitamin D’s antiproliferative effects appear to be linked to cell 
cycle perturbations.  As stated previously, progression through the cell cycle is regulated 
by cyclins, cyclin-dependant kinases (CDKs) and CDK inhibitors (CKIs, including p21 
and p27).  CKIs inhibit proliferation, in part by inducing cell cycle arrest in G0/G1.  As 
mentioned earlier, CDKN1A, which encodes p21, and GADD45A contain VDREs and are 
direct transcriptional targets of vitamin D.  Vitamin D also represses TYMS, which 
encodes for thymidylate synthase, and TK1, which encodes for thymidine kinase, both of 
which are key in DNA replication (Trump et al., 2010).   
Vitamin D has many indirect effects on cell cycle progression and can indirectly 
affect transcription via cross-talk with other signaling pathways.  While tumor cells treated 
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with vitamin D are inhibited in progression through the cell cycle, the molecular basis for 
this effect can differ from one tumor cell type, to another; consequently, we have yet to 
determine the exact mechanism of vitamin D-mediated cell cycle perturbation (Trump et 
al., 2010). 
In addition to its antiproliferative effects, vitamin D modulates mediators of 
apoptosis; it represses the expression of the pro-survival proteins Bcl-2 and Bcl-XL and can 
induce the expression of pro-apoptotic proteins (Bax, Bad, and Bak).  Vitamin D may also 
activate caspase effector molecules, and can destabilize telomerase reverse transcriptase 
(TERT) mRNA – inducing apoptosis through the shortening of telomeres (Trump et al., 
2010). 
Recent studies have linked vitamin D and autophagy and have speculated that 
vitamin D-induced autophagy may play a key role in the tumor-suppressing effects of 
vitamin D via interactions with autophagy associated genes and proteins such as beclin-1 
and ATG5 (Hoyer-Hansen et al., 2005; Hoyer-Hansen et al., 2007; Hoyer-Hansen et al., 
2010; Wang et al., 2008; Yuk et al., 2009).  While the mechanism has yet to be elucidated, 
one way in which vitamin D-induced autophagy could sensitize cells is through lysosomal 
permeabilization; a hallmark of autophagic induction, by increasing the volume and 
activity of the lysosomal compartment, this allows for lysosomal destabilization. 
Alternatively, by inducing cytoprotective autophagy, vitamin D could also protect tumor 
cells against cell death triggered by nutrient deprivation and hypoxia in the tumor 
environment (Hoyer-Hansen et al., 2010).   
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1.13 Previous work from the laboratory 
 Our laboratory has studied the use of vitamin D3 and two vitamin D3 analogs, 
EB1089 and ILX23-7553, in combination with Adriamycin (doxorubicin, the 
topoisomerase II poison) and radiation.  EB1089 (seocalcitol or 22E,24E-Diene- 
24,26a,27a-trihomo-1α,25(OH)2-vitamin D3), originally developed by Leo Pharmaceuticals 
in Demark, has been shown to be a more potent derivative than it parental compound in its 
regulation of cancer cell growth.  Conversely, EB1089 has been shown to have a 50% 
reduction in the regulation of calcium metabolism (Hansen et al., 2001).  ILX23-7553 
(originally developed by Hoffman LaRoche Inc. as Ro23-7553) has also been shown to 
potently inhibit the growth of tumors.  The structures of EB1089, ILX23-7553, and the 
active form of vitamin D3, 1,25D3, are presented in Figure 1.8.   
 Previous data indicated that both 1,25D3 and EB1089 can slow the growth of 
MCF7 breast tumor cells and significantly decrease cell viability and colony formation 
after exposure to 10 Gy or 5x2 Gy IR and Adriamycin (Chaudhry et al., 2001; Demasters 
et al., 2006; DeMasters et al., 2004; Sundaram and Gewirtz, 1999; Sundaram et al., 2003).  
EB1089 has also been shown to enhance the effects of IR in vivo using MCF7 breast tumor 
xenografts in nude mice (Sundaram et al., 2003).  EB1089, in combination with IR or 
Adriamycin in vitro, increased DNA fragmentation and apoptosis; however, the percentage 
of apoptosis observed (no more than 8%) was inconsistent with the dramatic sensitization 
(over 87% at 96 hours following radiation) observed with this combinational treatment 
(Demasters et al., 2006; DeMasters et al., 2004).  Additional data further indicated that an 
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alternative mode of cell death, most likely autophagy, could serve as the mechanism of 
sensitization (Demasters et al., 2006).   
 ILX23-7553 was also shown to significantly sensitize MCF7 breast tumor cells to 
IR and Adriamycin(Chaudhry et al., 2001).  Collectively, the studies with EB1089 and/or 
ILX23-7553 also suggested a requirement for functional p53 in the analogs’ ability to 
sensitize tumor cells to IR or Adriamycin(Gewirtz et al., 2000; Sundaram and Gewirtz, 
1999; Sundaram et al., 2000).   
 While our laboratory has previously established EB1089’s ability to sensitize breast 
tumor cells to IR, more work is needed to better understand the mechanism of 
sensitization.  Previous studies monitored apoptosis, senescence, mitotic catastrophe and 
alterations in DNA repair; these data were not able to account for EB1089’s ability to 
radiosensitize MCF7 breast tumor cells.  Consequently, preliminary studies indicated 
EB1089 in combination with IR induced an increase in autophagy.   
 Current studies have been expanded to include both EB1089 and 1,25D3, and their 
ability to induce autophagy in combination with IR.  Studies also assess vitamin D3’s 
ability to sensitize radioresistant breast tumor cells.  Moreover, vitamin D3’s ability to 
radiosensitize breast tumor cells is investigated in the presence of pharmacological and 
genetic inhibition of autophagy.  Pharmacological inhibition with radiation alone is tested 
both in vivo and in vitro utilizing the mouse mammary tumor cell line, 4T1.  Finally, the 
mechanism(s) responsible for vitamin D3’s enhancing effects on radiation are also 
addressed.    
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1,25D3 
EB1089 
ILX23-7553 
Figure 1.8: Vitamin D related structures. 
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CHAPTER 2 
2.1 Materials  
RPMI 1640 l-glutamine, trypsin-EDTA (1×; 0.05% trypsin, 0.53 mmol/L EDTA-4 
Na), penicillin/streptomycin (10,000 units/mL penicillin and 10 mg/mL streptomycin), and 
fetal bovine serum were obtained from Life Technologies (Gaithersburg, MD). Defined 
bovine calf serum was obtained from Hyclone Laboratories (Logan, UT).  EB 1089 was 
provided by Dr. Lise Binderup of Leo Pharmaceuticals (Bellarup, Denmark). Reagents 
used for the terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling assay 
(terminal transferase, reaction buffer, and fluorescein-dUTP) were purchased from 
Boehringer Mannheim (Indianapolis, IN). X-gal was obtained from Gold Biotechnology 
(St. Louis, MO).  The following materials were obtained from Sigma Chemical (St. Louis, 
MO): 1,25 Vitamin D3, trypan blue solution, formaldehyde, acetic acid, albumin bovine 
(bovine serum albumin), N-acetyl-l-cysteine, reduced glutathione (GSH), 4′,6-diamidino-2-
phenylindole (DAPI), and DMSO.  Acridine orange was purchased from Invitrogen 
(Eugene, OR). M-PER mammalian protein extraction reagent was purchased from Thermo 
Scientific (Rockford, IL).   
 
2.2 Cell Lines  
The p53 wild-type (WT) MCF7 human breast tumor cell line was obtained from 
National Cancer Institute (Frederick, MD). BT474 and Hs578t cells as well as the non-
cancerous MCF10a cell line were obtained from ATCC.  Development of the 
MCF7/ATG5-/- cells is described below.  The MCF7 RFP/LC3 construct was a generous 
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gift from Dr. Keith Miskimins (Bampton et al., 2005). The MCF7/ATG7-/- cells were a 
generous gift from Dr. Ameeta Kelekar (Separovic et al., 2010).  The MCF7/HER2 cells 
were a generous gift from Dr. Zhen Fan (Liang et al., 2003).  4T1 cells were a generous 
gift from Dr. Fred Miller(Aslakson and Miller, 1992) and 4T1-luc cells were obtained from 
Caliper.  
 
2.3 Cell Culture and Treatment  
All MCF7 derived cell lines were grown from frozen stocks in basal RPMI 1640 
supplemented with 5% FCS, 5% BCS, 2 mmol/L l-glutamine, and penicillin/streptomycin 
(0.5 mL/100 mL medium).  MCF7/ATG5-/- were maintained using (200µg/ml) puromycin 
(Sigma p8833) for resistance.  MCF7/HER2 cells were maintained using (200µg/ml) G418 
(Gibco 10131-035). BT474 cells were grown from frozen stocks in DMEM supplemented 
with 10% FCS, 2 mmol/L l-glutamine, and penicillin/streptomycin (0.5 mL/100 mL 
medium).  Hs578t cells were grown from frozen stocks in alpha-DMEM supplemented 
with 10% FCS, 2 mmol/L l-glutamine, and penicillin/streptomycin (0.5 mL/100 mL 
medium).  MCF10a cells were maintained in DME/F-12 1:1 media supplemented with 
2.5mM Glutamine, 15mM HEPES Buffer, 10% Horse Serum, 2 mmol/L l-glutamine, and 
penicillin/streptomycin (0.5 mL/100 mL medium), Insulin (10mg/ml): 500µl, CholeraToxin 
(1mg/ml): 50µl, Hydrocortizone (1mg/ml): 250µl, (100 mg/ml): 100µl EGF.   All cells were 
maintained at 37°C under a humidified, 5% CO2 atmosphere.  Cells were routinely 
subcultured by trypsinization (0.25% trypsin, 0.03% EDTA, Gibco) upon reaching 
confluence.  All experiments were examined by microscope for bacterial and fungal 
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contamination prior to experiments.  Additionally, all cell lines were determined to be free 
of mycoplasma.  Some cells were exposed to γ-IR using a 137Cesium irradiator. In our 
studies, some cells were exposed to 100 nmol/L EB1089 (Leo Pharmaceuticals batch no. 
EB1 262160) or 1,25 Vitamin D3 (Sigma D1530) for 72 hours before irradiation. This 
sequence of exposure was based on the studies by Wang et al. (Wang et al., 2000) and our 
own previous work, (Chaudhry et al., 2001; DeMasters et al., 2004; Sundaram et al., 2003) 
which have shown a requirement for prolonged incubation with vitamin D3 or its analogues 
to promote sensitivity to Adriamycin and irradiation.  In the cases where the radiation 
doses were fractionated, five fractions of 2Gy radiation were administered on three 
consecutive days (two fractions separated by 6 hours on the first 2 days followed by a fifth 
dose on the 3rd day). 
2.4 Cell viability  
 Cell viability was determined by trypan blue exclusion at various time points.  
Cells were plated in triplicate at varying densities depending on the cell line and treatment 
length (500 or 10,000 cells per well) in 6-well plates.  After overnight incubation to allow 
for surface adherence, 100nM of EB1089 or 1,25D3 were added for 72 hours.  EB1089 or 
1,25D3 were then removed, the cells were washed with 1X PBS then fresh media was 
added.  Cells were then exposed to 5x2Gy IR.  At appropriate time points, cells were 
harvested using trypsin, stained with 0.4% trypan blue dye (Sigma T8154), and counted 
using a hemocytometer with phase contrast microscopy or the Invitrogen Countess 
automated cell counter.   
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2.5 Clonogenic survival 
 For clonogenic survival studies, cells were plated in triplicate in six well tissue 
culture dishes at the appropriate density for each condition (typically 100 cells per well). 
After 10-14 days, the cells were fixed with 100% methanol, air-dryed and stained with 
0.1% crystal violet (Sigma C3886). For computing the survival fraction, groups of 50 or 
more cells were counted as colonies. Data were normalized relative to untreated controls, 
which were taken as 100% survival. 
 
2.6 Terminal Deoxynucleotidyl Transferase–Mediated dUTP Nick End Labeling 
Assay for Apoptosis  
 The method of Gavrieli et al. (Gavrieli et al., 1992) was used as an independent 
assessment of apoptotic cell death in combined cytospins containing both adherent and 
nonadherent cells. Cells were fixed and the fragmented DNA in cells undergoing apoptosis 
was detected using the In situ Cell Death Detection kit (Roche 11373242910, 
03333566001), where strand breaks are end labeled with fluorescein-dUTP by the enzyme 
terminal transferase. Cell suspensions were cytospun onto glass slides and stored at 4oC 
until stained.  The slides were fixed by immersion in 4% formaldehyde/PBS solution for 
10 minutes at RT.  Following 2 washed with PBS for 5 minutes each at RT, the slides were 
immersed in a 1:2 dilution of glacial acetic acid to ethanol at -20oC for 5 minutes.  The 
slides were again washed twice with PBS at RT.  Using an ImmunoPen (calibiochem, San 
Diego, CA) a tight circle was drawn around cells to allow containment of the following 
solutions.  The following steps were performed in a humidified chamber covered with 
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aluminum foil.  The cells were blocked with 50µL of bovine serum albumin (BSA)/PBS 
(1mg/ml) solution for 30 minutes at RT; after removal of BSA, cells were again washed 
twice with PBS for 5 minutes each at RT.  The cells were then incubated at 37oC for 1 hour 
with an enzyme mix consisting of 4 µL of 5X reaction buffer, 0.2µL terminal transferase, 
2µL 25mM CoCl2, 0.4µL Fluorescein-12-dUTP, and 13.4µL water per sample.  The 
enzyme mix was then removed and again washed twice with PBS for 5 minutes each at 
RT.  The cells were then mounted using Vectashield mounting medium (Sigma D9542) 
containing 1:1000 DAPI.  Pictures were taken using an Olympus inverted fluorescence 
microscope.  TUNEL positive cells were quantitated by counting number of positive cells 
per field; three representative fields were averaged per condition.  All images presented are 
at the same magnification. 
 
2.7 Western Blot Analysis  
(a.) Protein Isolation 
Cells were typically plated at a density of 50,000-100,000 cells per 10cm culture 
dish.  After the indicated treatments and at appropriate time points, cells were washed with 
cold PBS and lysed using 500-1000 µL M-PER mammalian protein extraction reagent 
(Thermo Scientific #78501) containing protease and phosphatase inhibitors for 5 minutes 
on a shaker.  The lysis was then collected and centrifuged for 5 minutes at 10,000rpm.  
Supernatent was collected and stored at  
-80oC until day of western.   
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(b.) Lowry Assay for Protein Concentration 
 Protein concentrations were determined by the Lowry method (citation – Lowry 
OH et al 1951).  Dilutions of isolated proteins were compared to a standard curve using 
various doses of BSA.  Absorbance at 750um was then determined using an Ultraspec 300 
UV/Visible Spectrophotometer.   
 
(c.) Electrophoresis 
 Concentrations determine by the Lowry assay allowed for equal aliquots of protein 
(35-50 µg) were added to 5X sample buffer (60mM Tris-base (pH 6.8), 25% glycerol, 2% 
SDS, 14.4mM 2-mercaptoethanol, 0.1% bromophenol blue) and diluted to equal volumes 
(30µl) water.  The samples were then loaded onto a polyacrylamide gel (8-15% - 
depending on the molecular weight of the protein being analyzed) and separated using 
SDS-PAGE running buffer for 0.5-2 hours with 60 milliamps constant current. Proteins 
were then transferred onto a nitrocellulose membrane electrophoretically for 1 hour at 100 
volts in transfer buffer at 4oC.   
 
(d.) Immunoblotting 
The membrane was blocked in TBS-Tween 20 buffer containing 5% nonfat dry 
milk or Odyssey blocking buffer for one hour.  After removal of the blocking buffer, 
membranes were immunoblotted with respective primary antibodies overnight at 4oC with 
an orbital shaker.   Primary antibodies were removed and the blot was washed 5 times, five 
minutes each in blotto wash.  The membranes were then incubated with the respective 
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horseradish peroxidase–conjugated or Odyssey secondary antibodies for 30 minutes. 
Proteins were visualized using an enhanced chemiluminescence kit from Pierce (Thermo 
Scientific #34080) and the light emission from the oxidation reaction exposed to 
audioradiography film or via the Odyssey Infrared Imaging System.  Primary antibodies 
used were anti-p62 (SQSTM1 – Santa Cruz sc-28359), anti-ATG5 (APG5 – Biosensis R-
111-100), anti-ATG7 (APG7 – Santa Cruz sc-33211), anti-VDR (Santa Cruz sc-13133), 
anti-ß actin (Santa Cruz sc-47778).  
 
2.8 Detection of Autophagic Cells  
(a.) Acridine Orange  
As a marker of autophagy, the volume of the cellular acidic compartment was 
visualized by acridine orange staining. (Paglin et al., 2001) Cells were seeded in six well 
tissue culture dishes and treated as described earlier for the cell viability study. 24 hours 
following treatment, cells were incubated with medium containing 0.4 µM acridine orange 
(Invitrogen A3568) for 15 minutes; the acridine orange was then removed, cells were 
washed once with PBS, fresh media was added, and fluorescent micrographs were taken 
using an Olympus inverted fluorescence microscope. Again, all images presented are at the 
same magnification.  The number of cells with increased acidic vesicular organelles was 
determined by counting at least three representative fields per treatment condition. 
 
(b.) Transmission Electron Microscopy (TEM) 
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TEM services, including sample fixation, embedding, ultra-microtomy and staining 
were provided by the VCU Department of Anatomy and Neurobiology Microscopy 
Facility.  Electron Microscopy Cells were harvested from culture and 1x10 5 cells were 
plated per plate on Permanox Petri dishes.  Various drug treatments were performed until 
endpoint.  At each time point, cells were washed with 1X PBS and then fixed with 2% 
paraformaldehyde/2 % glutaraldehyde in 0.1M sodium cacodylate buffer.  After 1 hour at 
room temperature, fixative was removed and replaced with 0.1M sodium cacodylate 
buffer, pH 7.4. Plates were then fixed in 1% osmium tetroxide in 0.1M-cacodylate buffer 
for one hour, after which are they were rinsed in 0.1M cacodylate buffer for 5-10 minutes.  
The plates were then dehydrated in graded ethanol series:  50%, 70%, 80%, 95%; for 5-10 
minutes each.  Then cell plates are were dehydrated in 100% ethanol 3X, 10-15 minutes 
each.  This was followed by propylene oxide 3X, 10–15 minutes each.  Cells were then 
infiltrated with 50/50 mix of propylene oxide and PolyBed 812 resin mix – overnight +. 
Next, the cells were infiltrated with pure PolyBed 812 resin (Polysciences, Inc.)mix –  + 
hours and overnight.  The cells were placed in embedding molds can then be 
embeddedcontaining PolyBed 812 and placed in 60˚C oven overnight to polymerize.  
Sectioning is done using Leica EM UC6i Ultramicrotome (Leica Microsystems).  For 
electron microscopy, 70-90 nm thick sections were collected on copper mesh grids and 
stained with 5% uranyl acetate and Reynold’s lead citrate.  Images are taken using JEOL 
JEM-1230 TEM (JEOL USA, Inc.) with the Gatan Ultrascan 4000 digital camera (Gatan 
Inc, Pleasanton, CA).  The magnification of image is indicated at the bottom of micrograph 
images. 
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2.9 RNA interference 
MCF7 cells were developed to silence the expression of ATG5.  ATG5 shRNA 
oligonucleotides were designed according to the sequence described previously (Fung et 
al., 2008).  For each set, top- and bottom-strand oligos were synthesized separately and 
annealed together. The primers for siRNA corresponding to the coding region were as 
follows: top,  
5'- gatccccGGATGAGATAACTGAAAGGttcaagagaCCTTTCAGTTATCTCATCCttttta -
3'  
and bottom,  
5'- gatccccGGCATTATCCAATTGGTTTttcaagagaAAACCAATTGGATAATGCCttttta -
3'; 
The BglII restriction site was included on the top strand at its 5' end; the HindIII restriction 
site was included at the 3' end to facilitate cloning into the pSUPER-retro-puro 
(OligoEngine, VEC-PRT-0002). The 2 oligos were annealed and inserted into the empty 
vector that has been linearized with BglII and HindIII enzymes. Positive clones were 
identified and sequenced and confirmed by automated DNA sequencing.  
 
2.10 Animals.   
 Female BALB/c mice, 8 weeks old, were purchased from Jackson Laboratories and 
were housed in our animal research facility.  Mice were kept in groups of four per cage and 
were fed with clean food and water.  The animals were acclimated at least two days before 
use and maintained throughout at standard conditions: 24±2oC temperature; 50±10% 
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relative humidity.  All studies involving mice were approved by the Institute’s Animal 
Care and Use Committee.   
 
2.11 In vivo tumor experiment.   
 Female BALB/c mice were challenged s.c. with 5 x 104 4T1 mouse breast tumor 
cells, transfected with luciferease, in the right flank on day 0.  On day 3, animals were 
injected with 150 mg/kg luciferin and the presence of primary tumors was determined by 
bioluminescence signal as imaged using an IVIS 50 (Xenogen, part of Caliper Life 
Sciences).  Of note, the bioluminescent signal could be detected in the animal before 
primary tumors were palpable and could be measured with a caliper.  Tumor-bearing mice 
were randomly assigned into groups and were injected intraperitoneally with their 
corresponding treatments: (a) 25 mg/kg CQ, (b) 50 mg/kg CQ, (c) 100mg/kg CQ, or (d) 
PBS.  Additionally experiments were conducted utilizing IR with the following 
corresponding treatments: (e) 5 Gy IR, (f) 10 Gy IR, (g) 15 Gy IR, (h) 10Gy IR + 14 days 
CQ ip. Each group had 6-8 mice. Therapy started on day 3 and was repeated every day for 
5 or 14 days for CQ or PBS treatment, and only on day 3 for IR treatment.  The tumor 
growth was monitored multiple times per week by an IVIS Spectrum.  After treatment 
ended, mice were further monitored until at least day 18 and were then sacrificed.  Tumors 
were resected and tumor volumes were observed.  Tumor growth was also evaluated by 
measurement of tumor diameters at various time points and the tumor volume was 
calculated as length x (width x 0.5)2.   
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2.12 Statistical Analysis 
All of the data are represented as means ± SE.  Statistical differences were 
determined using StatView statistical software. Comparisons were made using a one-way 
ANOVA followed by Tukey Kramer's post-hoc test. Ps ≤ 0.05 were taken as statistically 
significant. 
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CHAPTER 3: Influence of Vitamin D3, and its analog, EB1089, on the response to 
fractionated radiation in MCF7 cells 
 
3.1 The combination of EB1089 and radiation promotes extensive autophagy. 
 1,25D3 and vitamin D3 analogs have previously shown to promote growth arrest 
(Jensen et al., 2001; Sundaram and Gewirtz, 1999; Sundaram et al., 2003; Welsh et al., 
2003) or apoptosis in breast tumor cells, depending on the concentration used, and the cell 
line studied (Hansen and Maenpaa, 1997; Hoyer-Hansen et al., 2005; Polar et al., 2003; 
Welsh et al., 2003).  Previous studies in our laboratory demonstrated EB1089’s ability to 
enhance the response to IR as well as the involvement of autophagy in radiosensitization 
(Demasters et al., 2006; DeMasters et al., 2004; Sundaram and Gewirtz, 1999; Sundaram 
et al., 2003).  Our current studies were designed to expand upon the previous work by 
focusing on the mechanism of cell death induced by the combination of EB1089 with 
radiation and to include studies with the active form of vitamin D3, 1,25D3.  As with our 
previous observations, the promotion of autophagy in MCF7 cells exposed to EB1089 + 
radiation was confirmed based on acridine orange staining of autophagosomes, 
redistribution of RFP-LC3 and electron microscopy evidence of autophagic vacuole 
formation.  Quantification for each study is presented in an accompanying bar graph.  
Figure 3.1 shows punctate acridine orange staining, indicative of autophagy, (Paglin et al., 
2001) in cells treated with EB1089 followed by radiation; acridine orange vesicle staining 
in MCF7 cells exposed to tamoxifen was utilized as a positive control for autophagy 
(Bursch et al., 2000).  In contrast, untreated control cells or cells treated with EB1089 
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Control EB1089 IR 
 EB+IR Tamoxifen 
Figure 3.1: Promotion of autophagy by EB1089 + radiation in MCF-7 cells-Acridine orange 
staining of autophagic vesicles. Cells were exposed to 100 nM EB1089 for 72 hours alone, 
radiation alone (5x2Gy administered over a period of 3 days) or EB1089 for 72 hours which was 
then removed and followed by radiation. 2µM of tamoxifen for 72 hours was utilized as a positive 
control for AVO staining.  AO images were taken 24 hours post-irradiation using an inverted 
fluorescence microscope.  Average number of AVOs per cell was counted in three fields for each 
condition and is represented in the above graph.  *p<0.05, **p<0.0001 
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alone exhibit little or no orange punctate staining; of note to the subsequent studies in 
which autophagy was blocked in irradiated cells, cells treated with radiation alone exhibit 
an increase in punctate acridine orange vesicle staining over that observed in controls.   
In Figure 3.2, MCF7 cells stably transfected with RFP-tagged LC3 demonstrate a 
significant increase of red punctate fluorescence with radiation alone as well as with 
1,25D3 followed by radiation, indicative of LC3II association with the autophagosomal 
membrane. (Kirisako et al., 2000)  In contrast, a diffuse pattern of staining is observed in 
controls and in cells treated with 1,25D3 alone. 
Electron microscopy (EM) further confirmed the induction of autophagy upon 
treatment of the cells with EB1089 followed by radiation; Figure 3.3 shows representative 
double membraned autophagosomal structures encapsulating cellular organelles for 
radiation alone and for EB1089 + radiation. (Boya et al., 2005; Lambert et al., 2008; 
Livesey et al., 2009; Wu et al., 2008)  Autophagosomal vesicle formation was quite 
extensive with the combination treatment but relatively low with radiation alone, and was 
essentially absent in control cells or in cells treated with EB1089 alone.  
While previous studies indicated apoptosis may also be a factor in EB1089 
radiosensitization, our current studies did not indicate a substantial increase in the level of 
apoptosis observed in cells treated with EB1089 alone, radiation alone, or the combination 
of EB1089+IR (Figure 3.4), as indicated by the lack of TUNEL staining, and intact nuclei 
observed with DAPI; these findings as well as the absence of evidence for mitotic 
catastrophe (DeMasters et al., 2006) were consistent with the premise that autophagy is 
likely to play a major role in the cytotoxic effects of EB1089 in combination with IR.   
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3.2 1,25D3 alters the response to ionizing radiation from growth arrest to cell death in 
breast tumor cells. 
To confirm that 1,25D3 elicited the same response as EB1089 in our system, MCF7 
breast tumor cells were treated with 1,25D3 alone, 5x2Gy IR alone, or 100nM 1,25D3 
followed by 5x2Gy, and cell viability was determined at various times post-irradiation 
(Figure 3.5).  As with EB1089, 1,25D3 initially demonstrates a reduction in cell growth;  
when 1,25D3 is removed, cells rapidly regain proliferative capacity.  Cells exposed to 
radiation alone continue to proliferate at a greatly reduced rate and subsequently arrest for 
a period of 4-6 days post-irradiation; it is of particular importance to note that the cells 
recover proliferative capacity following this period of arrest.  Pretreatment with 1,25D3 
alters the cellular response to subsequent radiation, markedly attenuating cell viability by 
60% from that of IR alone at day 7, and by over 84% at day 12 following radiation with no 
subsequent recovery.  Likewise, Figure 3.6 demonstrates the impact of the treatment 
combining 1,25D3 with ionizing radiation on clonogenic survival. While radiation alone 
significantly reduces colony formation (74%) in comparison to control cells, 1,25D3 in 
combination with radiation induces an 87% reduction in colony formation and a 73% 
reduction in colony size.  As explained previously by Demasters et al, (DeMasters et al., 
2004) the clonogenic survival assay is likely to under-represent the impact of the 
combination treatment as compared to radiation alone since the proliferative recovery that 
is evident in Figure 3.5 likely does not occur under the experimental conditions of the 
clonogenic survival assay because of the lack of cell to cell contact; consequently, the 
differences between radiation alone and the combination of 1,25D3 + radiation will not be 
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Figure 3.2 
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Figure 3.2: Promotion of autophagy by EB1089 + radiation in MCF-7 cells-RFP 
LC3 punctuate staining. MCF7 cells stably transfected with RFP-LC3 were treated as 
in Figure 3.1.  Diffuse and punctuate staining was monitored by fluorescence 
microscopy; images were taken 24 hours post-irradiation.  Average number of puncta 
per cell was counted in three fields for each condition and is represented in the above 
graph.  **p<0.0001 
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Figure 3.3 
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Figure 3.3: Promotion of autophagy by EB1089 + radiation in MCF-7 cells-
Electron Microscopy of autophagic vesicles. MCF7 cells were treated as in A. and 
were fixed and subjected to electron microscopy. Autophagic vacuoles are indicated by 
the red arrows. Scale bars indicate magnification.  Average number of autophagic 
vesicles per cell was counted in three fields for each condition and is represented in the 
above graph.  **p<0.0001 
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Figure 3.4: Staining for apoptosis with radiation or EB1089 + radiation. MCF7 cells were 
treated with IR or with EB1089 + radiation.  Apoptosis was analyzed by the TUNEL assay and 
DAPI staining 3 days post-irradiation.  Taxol treatment was used as a positive control for 
apoptosis (not shown).  
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Figure 3.5 
 
 
 
 
  
 
 
 
 
Figure 3.5 Influence of 1,25 D3 on the temporal response to fractionated radiation in 
MCF7 cells.  MCF7 cells were exposed to radiation alone (5x2Gy), or 100 nM 1,25D3 prior 
to irradiation (5x2Gy). Viable cell number was determined by exclusion of trypan blue at the 
indicated days following the initiation of radiation exposure. **   p < .0001 between 
corresponding days.   ↑ Indicates days when irradiation occurred.  ^ Indicates when 1,25D3 
was removed. 
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Figure 3.6 
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Figure 3.6: Influence of 1,25 D3 on colony formation in response to fractionated 
radiation in MCF7 cells.  Clonogenic survival was assessed after 14 days post-treatment.  
Values shown are from a representative experiment with triplicate samples for each condition. 
Average colony size was also determined for each condition via phase contrast microscopy 
and measured utilizing QCapturePro. * p<.05 and **   p < .0001 from control   
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as pronounced as for the studies presented in Figure 3.5.  
Confirmation that 1,25D3 radiosensitization is also through the promotion of 
autophagy was based on acridine orange staining of autophagosomes, redistribution of 
RFP-LC3 and electron microscopy evidence of autophagic vacuole formation together 
with western blotting for the degradation of p62 as a measure of autophagic flux.  
Quantification for each study is shown in an accompanying bar graph.  Figure 3.7 shows 
punctate acridine orange staining, indicative of autophagy, (Paglin et al., 2001) in cells 
treated with 1,25D3 followed by radiation.  In contrast, untreated control cells or cells 
treated with 1,25D3 alone exhibit little or no orange punctate staining; again cells treated 
with radiation alone showed a modest increase in AO staining in comparison to levels 
observed with the combination.   
In Figure 3.8, MCF7 cells stably transfected with RFP-tagged LC3, a significant 
increase of red punctate fluorescence is evident upon treatment with radiation or 1,25D3 
followed by radiation, indicative of LC3 association with the autophagosomal membrane; 
(Kirisako et al., 2000) in contrast, a diffuse pattern of staining is observed in controls and 
in cells treated with 1,25D3.  
Electron microscopy (EM) further confirmed the induction of autophagy upon 
treatment of the cells with 1,25D3 followed by IR; Figure 3.9 shows representative double 
membraned autophagosomal structures encapsulating cellular organelles for radiation 
alone and for 1,25D3+ radiation.(Boya et al., 2005; Lambert et al., 2008; Livesey et al., 
2009; Wu et al., 2008)  Autophagosomal vesicle formation was quite extensive with the 
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combination treatment but relatively low with radiation alone, and was essentially absent 
in control cells or in cells treated with 1,25D3 alone.  
It is now recognized that although autophagosome formation is a necessary 
component of the autophagic process, autophagosome formation can occur without 
completion of autophagy and degradation of the autophagosomal content; consequently, it 
becomes necessary to also assess autophagic flux. (Pankiv et al., 2007) To evaluate 
autophagic flux, levels of the p62 protein were monitored by Western blotting (Figure 3.10 
with accompanying bar graph). As a positive control, a decline in p62 levels was evident 
when the cells were serum starved. Treatment with 1,25D3 alone did not reduce and in fact 
appeared to moderately increase p62 levels. The combination of 1,25D3 and radiation 
clearly promoted robust autophagic flux, as indicated by the decline in p62 levels. 
Furthermore, radiation alone promoted a decline in p62 levels. While autophagic flux by 
radiation alone is generally consistent with the data generated in other assays, the fact that 
suppression of p62 was similar for radiation alone and the combination of 1,25D3 with 
radiation was unexpected and will be addressed in the Discussion. 
 
3.3 Molecular signals involved in the initiation of autophagy in response to vitamin D3 
and radiation 
There are a variety of molecular pathways that may initiate autophagy.  
Phosphorylation and activation of the molecular target of rapamycin (mTOR), a member of 
the phosphoinositide 3-kinase related kinase (PIKK) family and a central modulator of cell 
growth, may serve as the main negative regulator of autophagy in cancer cells(Wang et al., 
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2011).  Furthermore, various physiological and pathological conditions may cause 
discrepancy among ER protein folding load and capacity, which can lead to the 
accumulation of unfolded proteins in the ER lumen, a condition referred to as “ER stress”.   
ER stress can then initiate the signal transduction pathway known as the Unfolded Protein 
Response (UPR).  This pathway aims to reduce the protein load in the ER by organizing 
the temporal shut down of protein translation along with an increase of ER folding 
capacity gene.  If severe ER stress persists, this can initiate apoptosis or autophagy 
(Kouroku et al., 2007; Ogata et al., 2006; Szegezdi et al., 2006).  The molecular links 
between autophagy, mTOR, and ER stress, and how these stress pathways influence 
therapeutic outcome, remain largely undefined, making this topic a very important area for 
future research in cancer therapy.    
To elucidate the mechanisms involved in the initiation of autophagy following 
administration of radiation in the presence or absence of 1,25D3, western blot analysis was 
conducted for proteins involved in the ER stress and mTOR pathways.  To better allow for 
a time course following treatment, the dose of radiation administered was 5 Gy for these 
studies.   
Upon the induction of ER stress, eif2α becomes phosphorylated.  MCF7 cells 
received 5 Gy IR ± 72 preincubation with 1,25D3 and levels of both eif2α and p-eif2α were 
monitored at various time points following radiation (Figure 3.11).  Radiation alone did not 
appear to influence eif2α or p-eif2α; conversely, 1,25D3+IR induced significant 
accumulation of p-eif2α at one hour post-irradiation which was quickly diminished.  This 
suggests 5 Gy radiation alone is not sufficient to allow for the induction of substantial ER 
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stress; however, 1,25D3 + IR allows for phosphorylation of eif2α suggesting stimulation of 
ER stress.  The increase in ER stress via the combination may elicit the mechanism behind 
1,25D3+IR’s ability to convert radiation induced autophagy from cytoprotective to a 
cytotoxic.  There is clearly a need for additional components to be studied in this pathway 
to assess the roles of ER stress and the UPR in radiosensitization and experiments are 
currently being conducted. 
mTOR can serve as a negative regulator of autophagy.  To determine if this 
pathway is also involved in the differential responses with radiation and the combination, 
MCF7 cells were treated with 5 Gy IR ± 72 hr preincubation with 1,25D3 and levels of 
both mTOR and p-mTOR were monitored at various time points following radiation 
(utilizing the same conditions as presented with Figure 3.11).  No bands were observed 
with either mTOR or p-mTOR in any of the treatments (data not shown), suggesting this 
pathway may not be involved.  Accordingly, additional components in this pathway are 
being probed to better clarify mTOR’s involvement, if any in radiosensitization by 1,25D3.
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Figure 3.7 
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Figure 3.7: Influence of 1,25 D3 on AVO formation in response to fractionated 
radiation in MCF7 cells.  Autophagy was monitored based on acridine orange staining 
24 hours post-irradiation.  Average vesicle per cell was quantitated and is represented in 
the lower panel graph.  * p<.05 and **   p < .0001 from control   
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Figure 3.8 
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Figure 3.8: Influence of 1,25 D3 on RFP-LC3 distribution in response to 
fractionated radiation in MCF7 cells.  MCF7 cells stably transfected with RFP-LC3 
diffuse and punctate staining was monitored by fluorescence microscopy.  Again, images 
were taken 24 hours post-irradiation.  Average number of puncta per cell were counted in 
three fields for each condition and are represented in the bottom panel graph. **   p < 
.0001 from control   
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Figure 3.9 
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Figure 3.9: Electron Microscopy of autophagic vesicles. MCF7 cells were treated, 
fixed and subjected to electron microscopy. Autophagic vacuoles are indicated by the 
red arrows. Scale bars indicate magnification. Average numbers of autophagic vacuoles 
per cell were counted and are represented in the bottom panel graph.  **   p < .0001 
from control   
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Figure 3.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10.  Influence of 1,25 D3 on p62 degradation in response to fractionated 
radiation in MCF7 cells.  Autophagic flux was based on the decline in p62 levels 
monitored by Western blotting 24 hours post-irradiation. Actin was utilized as a loading 
control. Serum starvation was used as a positive control for autophagic flux. The 
accompanying bar graph presents densitometry from three separate westerns.  
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Figure 3.11: Western Blot analysis of ER stress proteins.  MCF7 cells received 5 Gy 
IR ± 72 preincubation with 1,25D3 and levels of both eif2α and p-eif2α were monitored 
at various time points following radiation.   
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                                          Chapter 4: Inhibition of autophagy 
 
4.1 Impact of autophagy inhibition on sensitivity to treatment.  
Given the ongoing controversy as to the differential impact of autophagy in various 
experimental systems, where autophagy is either cytoprotective or putatively the mode of 
cell death, (Gewirtz et al., 2009) studies were designed to test the premise that interference 
with autophagy would influence sensitivity to the treatment with 1,25D3 + radiation.  Three 
commonly used inhibitors of autophagy were initially evaluated both alone and in 
combination with tamoxifen (Figure 4.1). These included 3-methyladenine (10 mM), 
which is a PI3 kinase inhibitor, (Bursch et al., 1996) chloroquine (CQ) (25 µM), which 
prevents acidification and fusion between the autophagosome and the lysosome, (Solomon 
and Lee, 2009) and bafilomycin (100 nM), which is an inhibitor of the vacuolar-type H+-
ATPase (V-ATPase). (Shacka et al., 2006) Due in large part to the toxicity of 3-
methyladenine and bafilomycin, chloroquine was chosen as the pharmacological inhibitor 
of autophagy in our experimental system.  
Figure 4.2 indicates that exposure to CQ alone produced an increase in formation 
of yellow autophagosomal vesicles, consistent with its ability to prevent the completion of 
autophagy by blocking the acidification step. Essentially identical images were generated 
in studies by Zhao et al using chloroquine as an autophagy inhibitor in MDA-MB231 cells. 
(Zhao et al., 2005)   Figure 4.2 also confirms that chloroquine interfered with the 
acidification step of autophagy in response to treatment with 1,25D3 + radiation, based on   
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Figure 4.1 
Tamoxifen+ BAF 
Figure 4.1: Influence of autophagic inhibition on AVO formation in response to 
tamoxifen in MCF7 cells.  Autophagy was monitored based on acridine orange 
staining 24 hours following 72 hour incubation with tamoxifen.   
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Figure 4.2 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2:  Effect of autophagy inhibition on the response to radiation or 1,25D3 + 
radiation. MCF7 cells were treated with radiation alone or with 1,25D3 + radiation with or 
without concurrent treatment of 25 µM CQ.  Autophagy was monitored by acridine orange 
staining 24 hours post-irradiation.    
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Figure 4.3a:  Effect of autophagy inhibition on the response to radiation or 1,25D3 + radiation. 
Autophagic flux was based on the decline in p62 levels monitored by Western blotting 24 hours post-
irradiation. Actin was utilized as a loading control. Serum starvation was used as a positive control for 
autophagic flux. Densitometry from three separate westerns is presented in the lower panel.   
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Figure 4.3b:  Effect of autophagy inhibition on the response to radiation or 1,25D3 + radiation. 
The autophagic marker, LC3 was monitored by Western blotting 24 hours post-irradiation. Actin was 
utilized as a loading control. Serum starvation was used as a positive control for autophagic flux. 
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acridine orange staining; (Solomon and Lee, 2009) interference with tamoxifen-induced 
autophagy was used as a positive control (Figure 4.1).  Radiation in the presence or 
absence of 1,25D3, significantly reduced p62; this is consistent with previous AO, EM, and 
RFP-LC3 observations.  The autophagic flux induced by radiation or 1,25D3 + radiation is 
eliminated in the presence of chloroquine; evidence of this blockade of is presented in the 
p62 Western shown in Figure 4.3a with the accompanying bar graph.  Levels of p62 were 
markedly elevated for the combined treatment of chloroquine with 1,25D3 + radiation; 
enhanced p62 levels in the presence of autophagic inhibitors can also be an indication of 
significant autophagic flux.     
Another useful marker for the induction of autophagy is the cleavage of LC3I to 
LC3II.  Upon induction of autophagy, LC3I is covalently attached to 
phosphatidylethanolamine converting it to LC3-II, causing it to become membrane-
associated (Mizushima and Klionsky, 2007). Moreover, LC3 remains associated with the 
completed autophagosome via association with p62 (Mizushima and Klionsky, 2007; Yang 
et al., 2005).   In Figure 4.3b, MCF7 control cells have modest levels of LC3II; EB1089 
decreased LC3II levels, which is consistent with the reduced autophagy as demonstrated 
by the increase in p62 levels induced by 1,25D3 in Figure 4.3a.  Conversely, IR and EB+IR 
completely abrogate LC3; this corresponds to the abolishment of p62 levels, an LC3 
binding partner, observed with these treatments in Figure 4.3a. Moreover, CQ alone or in 
combination with IR or EB+IR induced massive accumulation of LC3 indicative of CQ’s 
inhibition of autophagic flux. 
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To confirm the role of autophagy in 1,25D3 radiosensitization, the next series of 
studies evaluated the temporal response of MCF7 cells to radiation or 1,25D3 + radiation 
when autophagy was suppressed by chloroquine. Figure 4.4 indicates that, as observed in 
our previous studies, cells treated with radiation alone undergo transient arrest that is 
followed by recovery of proliferative capacity. In dramatic contrast, cells treated with 
1,25D3 + radiation, even with a blockade to autophagy by CQ, appear to die and do not 
regain proliferative capacity; 1,25D3 or CQ alone resulted in only a modest and transient 
inhibition of growth. 
Although one expectation might have been that inhibition of autophagy would 
reduce the effect of the combination treatment, the potency of the 1,25D3 + radiation 
treatment was not suppressed by chloroquine; in fact, the impact of the combination 
treatment was moderately increased with chloroquine treatment (Figure 4.4). This 
observation does not, however, refute the conclusion that autophagy mediates the cytotoxic 
actions of the 1,25D3 + radiation combination treatment.  As shown in Figure 4.5, blocking 
autophagy induced by EB1089 + radiation with chloroquine resulted in the promotion of 
apoptosis, based on an increase in TUNEL staining and altered nuclear morphology as 
evident with DAPI staining.  Consequently, while autophagy appears to be the primary 
response to EB1089 + radiation, when autophagy is blocked the cells will die by the 
alternative pathway of apoptosis.   
An entirely unexpected finding was that in cells exposed to radiation where 
autophagy was suppressed by CQ, the temporal profile was similar to that of the 
combination treatment; that is, cell death was evident with an apparent complete 
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suppression of proliferative recovery. As shown by the TUNEL and DAPI staining images 
in Figure 4.5, the radiation treatment in autophagy-compromised cells resulted in extensive 
apoptosis. These observations raised the possibility that autophagy was also having a 
cytoprotective action in the irradiated cells, as previously suggested in studies by Apel et 
al. (Apel et al., 2008) and further addressed later in this chapter. 
 
4.2 Impact of autophagy inhibition on the sensitivity to irradiation in MCF10a cells. 
A fundamental limitation in chemotherapy is the toxicity to normal surrounding 
cells.  Previous data indicated vitamin D did not radiosensitize non-malignant MCF10A 
cells. (Polar et al., 2003)  We therefore sought to determine if the inhibition of autophagy 
would sensitize non-malignant MCF10a cells, an immortalized cell line derived from 
normal breast epithelial cells.(Soule et al., 1990) MCF10a cells were treated with 2Gy IR 
in the presence or absence of 25µM CQ, and cell viability was determined at a single time-
point post-irradiation (Figure 4.6).  Cells exposed to CQ alone exhibited a 22% reduction 
in cell number 7 days post-irradiation.  With radiation alone, MCF10a cells demonstrated a 
44% reduction in cell number at this same time point.  Finally, cells treated with the 
combination exhibited a 54% reduction in cell number suggesting a less than additive 
effect.    
             In order to confirm that radiation was able to promote autophagy in MCF10a cells, 
acridine orange was used to stain for autophagosomes.  Figure 4.7 shows punctate acridine 
orange staining, indicative of autophagy, (Paglin et al., 2001) in cells treated with radiation 
alone, similar to levels seen in MCF7 cells.  In contrast, untreated control cells exhibit little 
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or no orange punctate staining; again cells treated with CQ with or without radiation 
exhibited characteristic yellow punctate formation indicating CQ’s ability to reduce 
autophagosome acidification.   
 
4.3 Impact of silencing ATG related genes on susceptibility to 1,25D3 and irradiation. 
 Pharmacological inhibitors can induce non-specific effects.   To extend the findings 
generated by pharmacological inhibition of autophagy, we developed an MCF7 cell line 
(MCF7/ATG5-) in which ATG5, one of the critical autophagy associated genes, (Bampton 
et al., 2005) was silenced.  The western blot in Figure 4.8 indicates a significant reduction 
in the signal for ATG5 in these cells, although ATG5 expression is not completely 
silenced.  Acridine orange staining in Figure 4.9 (and quantification in the accompanying 
bar graph) confirms that the response of MCF7 vector control cells was similar to that of 
the parental MCF7 cells (Figure 3.7).  Acridine orange staining in Figure 4.10 indicates 
that the ATG5 knockdown cells exhibited modest intrinsic levels of acridine orange 
staining in the treatments with 1,25D3, radiation or 1,25D3 + radiation; however, none of 
the conditions significantly increased acridine orange staining.  The electron microscopy 
images in Figure 4.11 further confirm that the autophagy that is otherwise induced by 
either radiation alone or the 1,25D3 + radiation combination is significantly suppressed in 
the ATG5 knockdown cells. 
 In further studies to address both the putative cytoprotective actions of autophagy 
with radiation alone and the putative cytotoxic functions of autophagy for the combination 
treatment, the MCF7/ATG5- cells were exposed to either radiation alone or 1,25D3 
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Figure 4.4:  Effect of autophagy inhibition on the response to radiation or 1,25D3 + 
radiation. Viable cell number was determined by trypan blue exclusion on the indicated 
days following treatment.  ↑ Indicates dose of irradiation given.  Lower graph is same data 
as above, plotted on a different scale. 
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Control 
 EB + IR 
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TUNEL DAPI 4.5. 
Figure 4.5:  Effect of autophagy inhibition on the response to radiation or 1,25D3 + radiation. 
Effect of autophagy inhibition on promotion of apoptosis. MCF7 cells were treated with IR or with 
1,25D3 + radiation with or without concurrent treatment of 25µM CQ.  Apoptosis was detected by the 
TUNEL assay and DAPI staining (based on the integrity of cell nuclei) 3 days post-irradiation.  Taxol 
treatment was used as a positive control for apoptosis (not shown).  
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followed by radiation, and viable cell number was monitored for a period of 12 days after 
the last dose of radiation (Upper panel of Figure 4.12). It should be noted that the MCF7 
vector control cells responded to these treatments in the same manner as parental MCF-7 
cells (Lower panel of Figure 4.12); moreover there was no evidence for apoptosis as 
measured by TUNEL/DAPI in the MCF7 vector control cells (data not shown). These 
experiments in large part recapitulated the CQ findings presented in Figure 4.4 in that the 
prolonged growth arrest and proliferative recovery that occurs with radiation treatment was 
abrogated both for cells treated with radiation alone and those treated with 1,25D3 + 
radiation; moreover, these observations support the conclusion that interference with 
autophagy can also result in sensitization to radiation in the same experimental system 
where the promotion of autophagy appears to mediate increased sensitivity to radiation by 
either EB1089 or 1,25D3.   Figure 4.13 (TUNEL and DAPI staining) indicates that cell 
death in the MCF7/ATG5- cells occurred largely through apoptosis, again similar to the 
CQ data presented in Figure 4.5; moreover there was no evidence for apoptosis as 
measured by TUNEL/DAPI in the MCF7 vector control cells (data not shown).  The ATG5 
knockdown did not appear to detectably interfere with the suppression of autophagic flux 
(p62 degradation) induced by either serum starvation or the 1,25D3+radiation treatment, 
although that induced by radiation alone was diminished (Figure 4.14 and accompanying 
bar graph).   This suggests the knockdown of ATG5 did not completely interfere with 
autophagic flux (p62 degradation), this observation is discussed in more detail later.    
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Additionally, we obtained MCF7/ATG7- cells in which ATG7, another critical 
autophagy associated gene, (Bampton et al., 2005; Mizushima et al., 1998) was silenced; 
Figure 4.15 confirms the knockdown of ATG7.  Figure 4.16 indicates the MCF7/ATG7- 
cells have a relatively high basal level of autophagy, again based on AO staining; however, 
none of the treatments significantly increased the level of AO puncta.  The published 
literature would lead us to expect that Atg7 drives autophagy by converting inactive LC3-I 
into active LC3-II.  Alternatively, the knockdown of Atg7 appears to increase AVO levels.  
This observation has also been confirmed in CryABR120G Cardiomyocytes; ATG7 
knockdown induced the accumulation of misfolded proteins and aggregates while p62 
remained unaffected (Pattison et al., 2011).  Figure 4.17 presents a time course response to 
treatment in the ATG7 knockdown cells that confirms increased sensitivity to radiation 
(sustained arrest and lack of proliferative recovery) as well as maintenance of sensitivity to 
the combination treatment of 1,25D3+radiation.   
Due to the high basal AO punctate staining, we also evaluated autophagic flux in 
the MCF7/ATG7- cells based on degradation of p62 by Western blotting.  Figure 4.18 
indicates that none of the treatments significantly altered p62 levels, confirming the fact 
that in these cells, radiation induced stress fails to promote autophagy.   
It is of interest that both serum starvation and the 1,25D3+radiation combination 
promote p62 degradation in the ATG5 knockdown cells but no degradation is observed 
with the knockdown of ATG7, although this may have the trivial explanation that the 
blockade to autophagy is incomplete with ATG5. Additionally, ATG5 is only associated 
with one arm of the ATG conjugation cascade, (Nedelsky et al., 2008) and therefore it is 
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possible cells can still undergo autophagy by utilizing the conjugation of ATG4, ATG7, 
and/or ATG8; since ATG7 is involved in both arms of the cascade silencing of ATG7 is 
likely to be more effective in suppressing the autophagic response. Furthermore, as p62 
function is not limited solely to autophagy but is also associated with ubiquitin mediated 
protein degradation (Ding and Yin, 2008; Pankiv et al., 2007) it remains possible that our 
findings may reflect alternative and perhaps as yet undefined functions of p62. 
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Figure 4.6: Influence of autophagy inhibition on viability of “normal” MCF10A breast 
epithelial cells in response to radiation. MCF10a cells were exposed to radiation alone (2Gy) in the 
presence or absence of 25µM CQ.  Viable cell number was determined by exclusion of trypan blue at 
the indicated days following the initiation of radiation exposure.  
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Figure 4.7 
Control CQ 
IR 2 Gy IR + CQ 
Figure 4.7. Chloroquine inhibits AVO formation in MCF10a cells.  MCF10a cells 
were treated with 2 Gy IR in the presence or absence of CQ and stained with AO 24 
hours post irradiation.   
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Figure 4.8       
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Figure 4.8: Western blotting to determine level of ATG5 knockdown.  MCF7 cells 
transfected with siRNA scramble (Con) or 2 different vectors for the silencing of ATG5 
were monitored for the level of ATG5 protein.  Beta actin is utilized as a loading 
control. 
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Figure 4.9: AVO formation in vector control cells.  MCF7 cells transfected with the 
control vector were treated with IR in the presence or absence of 1,25D3 and the 
formation of AVO was monitored  
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Figure 4.10: AVO formation in ATG5 knockdown cells.  MCF7/ATG5- cells were 
treated with IR in the presence or absence of 1,25D3 and the formation of AVO were 
monitored.  Quantification of AVO is presented in the lower panel graph 
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Figure 4.11. Silencing of ATG5 in MCF7 cells inhibits autophagic vesicle formation.  
MCF7 cells were stably transfected with either an empty vector or with a plasmid for the 
silencing of ATG5. Electron Microscopic imaging does not indicate the formation of 
autophagosomes.  Scale bars indicate magnification. 
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Figure 4.12:  Influence of 1,25D3 on the response to fractionated radiation in 
MCF7/ATG5- cells.  ATG5-cells (top panel) or MCF7 vector control cells (bottom 
panel) were exposed to radiation alone (5x2 Gy), or 1,25D3 prior to irradiation and 
viable cell number was determined by exclusion of trypan blue at the indicated days 
following the initiation of radiation exposure. ↑ Indicates when irradiation occurred. ** 
p<0.0001 from IR on corresponding day, ┼ p<0.0001 comparing corresponding time 
points in MCF7/ATG5- cells and vector control cells. 
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Figure 4.13. Influence of 1,25D3 on Apoptosis in response to fractionated radiation 
in MCF7/ATG5- cells.  MCF7/ATG5-cells were exposed to radiation alone (5x2 Gy), 
or 1,25D3 prior to irradiation and apoptosis was monitored by the TUNEL assay and 
DAPI staining 3 days post-irradiation. 
 
 
 80 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14.  Influence of 1,25D3 on Autophagy in response to fractionated radiation 
in MCF7/ATG5- cells.  Cells were exposed to radiation alone, or 1,25D3 prior to 
irradiation and autophagic flux was based on the decline in p62 levels monitored by 
Western blotting 24 hours post-irradation. Actin was utilized as a loading control. Serum 
starvation was used as a positive control for autophagic flux.  Densitometry for p62 levels 
normalized for actin is presented in the lower panel.  **p<0.0001 from control 
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Figure 4.15.  Western blot analysis to determine level of ATG7 knockdown.  MCF7 
cells transfected with siRNA scramble or ATG7- vectors for the silencing of ATG7 
were monitored for the level of ATG7 protein in comparison to parental MCF7 cells.  
Beta actin is utilized as a loading control. 
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Figure 4.16. AVO formation in ATG7 knockdown cells.  MCF7/ATG7- cells were 
treated with IR in the presence or absence of 1,25D3 and the formation of AVO were 
monitored.   
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Figure 4.17:  Influence of 1,25D3 on the response to fractionated radiation in 
MCF7/ATG7- cells.  MCF7/ATG7-cells were exposed to radiation alone (5x2 Gy), or 
1,25D3 prior to irradiation and viable cell number was determined by exclusion of 
trypan blue at the indicated days following the initiation of radiation exposure. ↑ 
Indicates when irradiation occurred. IR and 1,25D3+IR data is replotted in lower graph 
with adjusted scale.   
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Figure 4.18. Influence of 1,25D3 on Autophagy in response to fractionated radiation in MCF7/ATG7- 
cells.  Cells were exposed to radiation alone, or 1,25D3 prior to irradiation and autophagic flux was based on 
the decline in p62 levels monitored by Western blotting 24 hours post-irradation. Actin was utilized as a 
loading control. Serum starvation was used as a positive control for autophagic flux.   
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Chapter 5: Influence of Vitamin D3, and its analog, EB1089, on the response to 
fractionated radiation in radiation resistant cell lines. 
 
5.1 Sensitization to radiation in MCF7/HER2 breast tumor cells.  
Given that primary breast cancer cells are generally considered to be relatively 
sensitive to radiation treatment, we sought to determine if treatment of breast tumor cells 
that are intrinsically resistant to radiation through the over expression of HER2/neu (Liang 
et al., 2003) would also demonstrate sensitization to radiation via the promotion of 
autophagy.  Figure 5.1 confirms the over expression of HER2 in this cell line while Figure 
5.2 confirms the expression of the vitamin D receptor. Figure 5.3 indicates that 
MCF7HER2 cells constitutively demonstrated low levels of autophagy staining (a single 
large vacuole is observed in control cells; in cells exposed to EB1089 there is no increase 
in AVO staining.  Treatment with radiation or EB1089 + radiation resulted in more widely 
dispersed punctate staining.  This is similar to our previous results in wild type MCF7 cells 
(and in separate studies by Eden Wilson in our laboratory, utilizing ZR-75 breast tumor 
cells).  Figure 5.4 demonstrates that the combination of 1,25D3 + radiation results in a 
more pronounced effect in terms of reducing viable cell number  than radiation alone, 
although this appears to be due in large part to high sensitivity to the effects of the 1,25D3; 
sensitization was also observed with EB1089 + radiation (data not shown).  In these 
studies, we did not follow radiation effects to the point where proliferative recovery might 
have been evident.  While other factors may play a role, the increased sensitivity to vitamin 
D3 alone is likely due to upregulation in VDR expression (Figure 5.2). 
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5.2 Sensitization of Hs578t breast tumor cells.  
A recent paper reported the radiosensitization by 1,25D3 of Hs578t breast tumor 
cells,
 
(Mineva et al., 2009) a breast tumor cell line that is p53 mutant and intrinsically 
radioresistant. (Mineva et al., 2009; Tian et al., 2007)  The clonogenic survival data 
presented in Figure 5.5 confirm that Hs578t cells are significantly less radiosensitive than 
MCF7 cells.  Figure 5.6 further confirms the findings of Mineva et al. (Mineva et al., 2009) 
that 1,25D3 enhances radiation sensitivity (1.7 fold reduction in colony formation with 
combination in comparison to radiation alone).  Figure 5.7 indicates that the combination 
of 1,25D3 with radiation resulted in significant autophagy in comparison to control and 
1,25D3 treated cells (with modest autophagy induced by radiation alone), based on acridine 
orange staining, findings similar to those with MCF7 and MCF7HER2 cells. Studies of 
p62 degradation shown in Figure 5.8 confirmed that exposure to 1,25D3 + radiation also 
promoted autophagic flux. It is further of importance to emphasize that radiation alone did 
not appear to promote p62 degradation in this cell line, which supports the premise that 
increased autophagic flux is likely to be responsible for radiation sensitization by 1,25D3.  
To asses whether radiation alone or in combination with 1,25D3 elicited apoptosis, 
TUNEL and DAPI staining were conducted (Figure 5.9 with corresponding 
quantification); while there was a significant increase in the level of apoptosis observed in 
cells treated with 1,25D3 in combination with radiation, levels observed were only that of 
15%.  This would indicate that apoptosis may play a role in 1,25D3 radiosensitization of 
Hs578t cells.   
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5.3 Lack of sensitization of BT474 breast tumor cells.  
To further test whether EB1089 was able to sensitize intrinsically radioresistant cell 
lines, we also examined HER2 over expressing, p53 mutant, BT474 breast cancer cells. 
(Monazzam et al., 2009)  Figure 5.10 indicates the temporal differences in viable cell 
number between control cells and cells that were treated with either radiation alone or 
EB1089 followed by radiation.  The BT474 cells were clearly quite resistant to radiation 
treatment. Since EB1089 was unable to radiosensitize these cells and upon further 
examination the combination was unable to elicit an autophagic response as indicated by 
the lack of change in acridine orange staining in Figure 5.11.   Although the literature 
indicates that BT474 cells express the VDR and are responsive to vitamin D, (Mehta et al., 
2003) Figure 5.2 revealed that BT474 cells actually have minimally detectable levels of the 
VDR, which supports the necessity for having a relatively robust VDR mediated signaling 
response pathway for radiosensitization by vitamin D3 or its analogs.  Interestingly, Costa 
et al. have suggested that the Vitamin D receptor may be unnecessary for its 
antiproliferative actions, which could indicate that effects on tumor cell growth and 
radiation sensitivity are dissociable. (Costa el at., 2009)  
 88 
 
 
 
 
 
 
Figure 5.1.  Western blot analysis to determine level of HER2.  MCF7/HER2 cells 
transfected for the over expression with HER2 were monitored for the level of HER2 
protein in comparison to parental MCF7 cells.  Beta actin is utilized as a loading 
control. 
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Figure 5.2.  Western blot analysis of VDR expression levels.  Vitamin D receptor 
(VDR) levels were monitored via Western blotting in MCF7 parental cells, 
MCF7HER2 cells, and BT474 cells. 
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Figure 5.3. AVO formation in MCF7/HER2 cells. MCF7/HER2 Cells were exposed 
to radiation alone (5x2 Gy), 1,25D3 alone, or 1,25D3 + irradiation and autophagy was 
monitored based on acridine orange staining 24 hours post-irradiation; for the 
accompanying bar graph, the average number of AVOs per cell were counted in three 
fields for each condition. 
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Figure 5.4. Temporal response to 1,25D3 and radiation in MCF7/HER2 cells.  
MCF7/HER2 cells were treated as in the previous figure and viable cell number was 
determined by exclusion of trypan blue at the indicated days following the initiation of 
radiation exposure.  ↑ Indicates days when irradiation occurred.   
 
 
 
0 
1 
2 
3 
4 
-8 -
6 
-4 -2 0 2 4 6 
Days post-irradiation 
Vi
ab
le
 
Ce
ll 
Nu
m
be
r 
(x1
06
) 
Control 
1,25D3 
IR 
1,25D3 +IR 
 ↑ ↑ ↑ ↑ ↑ 
 
MCF7/HER2 
 92 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 5.5. Radiation sensitivity of Hs578t breast tumor cells in comparison to 
MCF7 cells. MCF7 and Hs578t cell were treated with varying doses of radiation and 
colony formation was assessed. *p<0.05, **p<0.0001. 
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Figure 5.6. Influence of 1,25D3 on radiation sensitivity of Hs578t breast tumor 
cells. Hs578t cells were exposed to 1,25D3 alone, radiation alone (5x2 Gy), or 1,25D3 
prior to irradiation and colony formation was assessed. **p<0.0001. 
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Figure 5.7. AVO formation in Hs578t breast tumor cells. Hs578t cells were exposed 
to 1,25D3 alone, radiation alone (5x2 Gy), or 1,25D3 prior to irradiation and stained 
with acridine orange for the presence of AVO. 
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Figure 5.8. Influence of 1,25D3 and radiation on autophagic flux in Hs578t breast 
tumor cells.  Autophagic flux was based on the decline in p62 levels monitored by 
Western blotting 24 hours post-irradiation. Actin was utilized as a loading control. Serum 
starvation was used as a positive control for autophagic flux.  Densitometry of the 
p62/actin ratio from three separate westerns is presented in the lower panel.   
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Figure 5.9. Apoptosis in 
Hs578t breast tumor cells. 
Hs578t cells were exposed to 
1,25D3 alone, radiation alone 
(5x2 Gy), or 1,25D3 prior to 
irradiation and imaged with 
TUNEL and DAPI for the 
presence of apoptosis.  
Quantification is presented 
in the lower graph. 
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Figure 5.10. Temporal response to 1,25D3 and radiation in BT474 cells.  BT474 cells 
were exposed to 1,25D3 alone, radiation alone (5x2 Gy), or 1,25D3 prior to irradiation and 
viable cell number was determined by exclusion of trypan blue at the indicated days 
following the initiation of radiation exposure.  ↑ Indicates days when irradiation occurred.   
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Figure 5.11. Autophagy is not altered with 1,25D3 and radiation in BT474 breast 
tumor cells.  BT474 Cells were exposed to radiation alone, or 1,25D3 prior to irradiation 
and Autophagy was monitored based on acridine orange staining 24 hours post-irradiation. 
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Chapter 6: Influence of autophagic inhibition on the response to  
radiation in 4T1 mouse mammary tumor cells. 
 
6.1 Chloroquine, but not 1,25D3+IR, sensitizes 4T1 cells. 
 In vivo and in vitro studies of antitumor activity of cancer therapeutics can often 
result in differential responses.  It was therefore vital to determine if 1,25D3 promoted 
radiosensitivity in vivo.  Because the immune system can play an important role in both 
autophagy (Harris, J et al., 2009; Mizushima N, et al., 2008) and the response to 
chemotherapy in vivo (Zitvogel et al., 2008), we sought to utilize a mouse mammary tumor 
that could be used with immune competent mice.  We first chose to confirm that the 
mammary fat pad derived, highly metastatic, p53-null 4T1 cells (obtained from Fred Miller 
whom first isolated this cell line (Aslakson and Miller, 1992)), responded similarly to 
MCF7 cells.  4T1 cells were treated with 1,25D3 alone, 5x2Gy IR alone, or 100nM 1,25D3 
followed by 5x2Gy, and cell viability was determined at various times post-irradiation 
(Figure 6.1).  In contrast to the growth delay and proliferative recovery observed with 
MCF7 cells in Figure 3.5, 4T1 cells treated with IR alone demonstrate a growth delay 
followed by cell death.  Because of this response, there is not a dramatic difference 
between viability of 4T1 cells treated with radiation alone or 1,25D3 + radiation.  Similarly, 
colony formation post-irradiation (Figure 6.2) in the presence or absence of 1,25D3 is not 
significantly different.   
 4T1 cells stably transfected with luciferase (4T1-luc), to be utilized in vivo, were 
also obtained and cell viability was analyzed with 1,25D3 alone, 5x2Gy IR alone, or 
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Figure 6.1: Influence of 1,25 D3 on the temporal response to fractionated radiation in 
4T1 cells.  4T1 cells were exposed to radiation alone (5x2Gy), or 100 nM 1,25D3 prior to 
irradiation (5x2Gy). Viable cell number was determined by exclusion of trypan blue at the 
indicated days following the initiation of radiation exposure.  
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Figure 6.2: Influence of 1,25 D3 on colony formation in response to fractionated 
radiation in 4T1 cells.  Clonogenic survival was assessed after 10 days post-treatment.  
Values shown are from a representative experiment with triplicate samples for each 
condition.  
4T1 Colony Formation Assay
1
10
100
control 1,25D3 IR 1,25D3+IR
Co
lo
n
y 
Nu
m
be
r
 102 
 
 
 
 
 
0.00E+00 
5.00E+05 
1.00E+06 
1.50E+06 
2.00E+06 
2.50E+06 
3.00E+06 
-10 -5 0 5 10 15 
Days post-irradation 
Ce
ll 
N
u
m
be
r 
Control 
1,25D3 
IR 
1,25D3+IR 
4T1-luc 
Figure 6.3: Influence of 1,25 D3 on the temporal response to fractionated radiation in 
4T1-luc cells.  4T1 cells were exposed to radiation alone (5x2Gy), or 100 nM 1,25D3 prior 
to irradiation (5x2Gy). Viable cell number was determined by exclusion of trypan blue at the 
indicated days following the initiation of radiation exposure.  
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100nM 1,25D3 followed by 5x2Gy at various times post-irradiation (Figure 6.3).  Similar 
to the parental cells, 4T1-luc cells were not apparently radiosensitized with 1,25D3 
treatment.  To determine if autophagy played a role in response to radiation in this system, 
cells were treated as in Figure 6.3 in the presence or absence of 25µM CQ (Figure 6.4) and 
stained with acridine orange.  4T1-luc control cells exhibited high levels of basal 
autophagy that were unaltered in response to 1,25D3, IR, or 1,25D3.  Moreover, the 
presence of CQ dramatically decreased cell viability (note minimal cells observed per field 
of view in Figure 6.4, cell count data not shown).  Due to the high basal level of autophagy 
observed, an MTT assay was conducted to analyze the effects of various doses of CQ in 
these cells.  All doses except for 1µM were highly toxic to 4T1-luc cells (Figure 6.5).  In 
addition, a number of other autophagic inhibitors were analyzed via the MTT assay and 
demonstrated similar toxicity (data not shown), suggesting that the 4T1 cells rely on 
autophagy for viability and that inhibition of autophagy is highly detrimental to the cells.     
 
6.2 Chloroquine in combination with radiation in vivo  
 Expanding upon the observation that CQ was toxic to 4T1-luc cells in vitro, female 
BALB/c mice were challenged s.c. with 4T1-luc mouse breast tumor cells in the right flank 
and tumor-bearing mice were randomly assigned into groups of 6-8.  To determine which 
doses of CQ and IR to use, a dose response for each was conducted.  Experiments were 
conducted utilizing IR (administered on day 3 post-challenge) at the following doses: (a) 5 
Gy, (b) 10 Gy, (c) 15 Gy.  Utilizing data obtained in 4T1 cells treated with CQ alone  
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Figure 6.4. AVO formation in 4T1 cells. 4T1 cells were exposed to CQ or 1,25D3 
alone, radiation alone (5x2 Gy) ±CQ, or 1,25D3 prior to irradiation ±CQ and stained 
with acridine orange for the presence of AVO. 
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Figure 6.5: MTT indicates CQ is toxic to 4T1 cells.  4T1 cells were treated with various 
doses of CQ and toxicity was determined via MTT.   
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(Jiang et al., 2010) animals were injected intraperitoneally with their corresponding 
treatments: (a) 25 mg/kg CQ, (b) 50 mg/kg CQ, (c) 100mg/kg CQ, or (d) PBS; therapy 
started on day 3 post-challenge and was repeated every day for 5 days.  The tumor growth 
was monitored multiple times per week by an IVIS Spectrum.  After treatment ended, mice 
were further monitored until at least day 18 and were then sacrificed.  Tumors were 
resected and tumor volumes were observed.  Tumor growth was also evaluated by 
measurement of tumor diameters at various time points and the tumor volume was 
calculated as length x (width x 0.5)2.   
 At various time points post-challenge, mice were weighed to determine if any of 
the treatments reduced body weight.  As observed in Figure 6.6, none of the treatments 
altered body weight.  Tumor growth was monitored throughout the studies utilizing the 
IVIS 50 (Xenogen, part of Caliper Life Sciences) and calipers.  Of note, the 
bioluminescent signal could be detected in the animal before primary tumors were palpable 
and could be measured with a caliper.  Figure 6.7 and 6.8 present caliper and luminescence 
data, respectively.  Caliper data indicated that all CQ and IR treatments, by day 19, 
significantly reduced tumor volume in comparison to vehicle (Figure 6.7).  On day 19, 
tumor necrosis and over-saturation of luminescence confounded vehicle data (Figure 6.8).  
However, with trends observed on prior days, it appears that all doses of radiation inhibited 
tumor growth; conversely, CQ did not significantly alter tumor development as measured 
by bioluminescence.  Discrepancy between CQ caliper and bioluminescence data are 
probably due to the fact that calipers only measure the length and width of the tumor, but 
not the depth.  Tumor resection in Figure 6.9 confirms the observations in Figure 6.8.   
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Figure 6.6: CQ alone and IR alone do not influence animal weight.  Animal body weight 
was monitored at various time points post-challenge; CQ alone and IR alone are compared 
with vehicle treatment. 
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Figure 6.7. Influence of CQ alone and IR alone on tumor volume.  Tumor volume was 
monitored via caliper at various time points post-challenge; CQ alone and IR alone are 
compared with vehicle treatment. 
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Figure 6.8.  Influence of CQ alone and IR alone on bioluminescence.  Animals were 
injected with luciferin and bioluminescence was monitored at various time points post-
challenge; CQ alone and IR alone are compared with vehicle treatment. 
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Figure 6.9.  Influence of CQ alone and IR alone on tumor weight.  Animals were 
sacrificed and tumors were resected and weighed; CQ alone and IR alone are compared with 
vehicle treatment. 
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Given that 5 days of CQ did not appear to significantly alter tumor growth at any of the 
doses, a longer period of injections, 14 days, was chosen.  As in Figure 6.6, 14 days of CQ 
injections did not alter body weight (Figure 6.10).  Disappointingly, the longer CQ 
treatment also did not have significant effects on tumor development.  Figure 6.11 and 6.12 
indicates that the caliper and luminescence data, respectively, for CQ is not significantly 
different than vehicle.  Moreover, tumor resection in Figure 6.13 confirms these 
observations.  
 While in vitro data presented above and in vivo data in the literature (Jiang et al., 
2010) indicated that CQ treatment alone should significantly reduce 4T1 tumor 
development, this was not our observation.  This could be due to a variety of factors that 
are further elaborated upon in the discussion.  Nevertheless, we sought to determine if CQ 
could radiosensitize 4T1 tumor development.  BALB/c mice were challenged with 4T1 
tumors as before, received the following treatments: (a) 50mg/kg CQ for 14 days, (b) 10 
Gy IR, (c) IR + CQ, (d) PBS (vehicle), and monitored at various time points.  As observed 
in Figure 6.14, radiation, CQ or the combination did not significantly alter body weight as 
compared to vehicle.   Figure 6.15 and 6.16 present caliper and luminescence data, 
respectively.  Caliper data indicates that IR and IR+CQ significantly reduced tumor 
volume by day 8; additionally, CQ, IR, and IR+CQ treatments, by day 13, significantly 
reduced tumor volume in comparison to vehicle (Figure 6.15).  Luminescence data 
presented in Figure 6.16 indicates that IR significantly reduced luminescence from vehicle 
on days 8, 13, and 18.  Conversely, IR+CQ was not significant from vehicle at any time 
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point, and by day 18, CQ luminescence is significantly increased in comparison to vehicle 
(Figure 6.16).    At day 18, mice were sacrificed and tumors were resected.  Figures 6.17 
and 6.18 presents tumor weight and images, respectively.   Radiation, in the presence or 
absence of CQ, significantly reduced tumor weight in comparison to vehicle; however, due 
to variability of tumor weight, IR+CQ did not significantly reduce tumor weight in 
comparison with IR alone (Figure 6.17).  Moreover, radiation alone promoted 
approximately a 50% reduction in tumor development at our final time points.  This in vivo 
radiation time course is highly correlative with the in vitro radiation time course; in that, 
initially tumors develop at a reduced rate, followed by a period of growth arrest.  
Furthermore, in contrast to our original expectations, our data suggests that IR+CQ is not 
able to significantly reduce tumor formation over that of radiation alone.  The implications 
of this data are further discussed in Chapter 7.2.        
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Figure 6.10: CQ for 14 days did not influence animal weight.  Animal body weight was 
monitored at various time points post-challenge; CQ is compared with vehicle treatment. 
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Figure 6.11. Influence of CQ for 14 days on tumor volume.  Tumor volume was 
monitored via caliper at various time points post-challenge; CQ is compared with vehicle 
treatment. 
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Figure 6.12: Influence of CQ for 14 days on bioluminescence.  Animals were injected 
with luciferin and bioluminescence was monitored at various time points post-challenge; CQ 
is compared with vehicle treatment. 
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Figure 6.13.  Influence of CQ for 14 days on tumor weight.  Animals were sacrificed and 
tumors were resected and weighed; CQ is compared with vehicle treatment. 
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Figure 6.14: CQ, IR and IR+CQ do not influence animal weight.  Animal body weight 
was monitored at various time points post-challenge. 
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Figure 6.15: Influence of CQ, IR and IR+CQ on tumor volume.  Tumor volume was 
monitored via caliper at various time points post-challenge. *IR and IR+CQ p<0.05 from 
Veh on day 9. **CQ, IR, and IR+CQ p<0.0001 from Veh on days 13 and 18.   
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Figure 6.16: Influence of CQ, IR and IR+CQ on bioluminescence.  Animals were 
injected with luciferin and bioluminescence was monitored at various time points post-
challenge. *p<0.05 and **p<0.0001 
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Figure 6.17: Influence of CQ, IR and IR+CQ on tumor weight.  Animals were sacrificed 
and tumors were resected and weighed. *p<0.0001 from vehicle.  
 
 
 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
Veh CQ 50 IR 10 Gy IR+CQ
tu
m
o
r 
w
ei
gh
t (g
ra
m
s)
  * 
  * 
 121 
 
Figure 6.18: Images of resected tumors.  Animals were sacrificed and tumors were 
resected.  Representative tumor images are presented.   
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Chapter 7: Discussion 
7.1 In vitro data. 
The utility of combining with 1,25D3 or Vitamin D3 analogs with conventional 
chemotherapeutic drugs such as tamoxifen, platinum compounds, and Adriamycin against 
a variety of tumor cell lines is supported by multiple studies. (Hershberger et al., 2001; 
Light et al., 1997; Ravid et al., 1999; Vink-van Wijngaarden et al., 1994; Wang et al., 
2000) In addition, phase I and II clinical trials have suggested that high dose intermittent 
therapy with 1,25D3 itself is potentially safe. (Trump et al., 2006) Our previous work 
(Chaudhry et al., 2001; Demasters et al., 2006; DeMasters et al., 2004; Sundaram et al., 
2003) has focused on utilizing 1,25D3 and its analogs to confer sensitivity to radiation in 
the breast tumor cell, apparently through the promotion of autophagy. (Demasters et al., 
2006; DeMasters et al., 2004) Previous studies suggested that apoptosis and mitotic 
catastrophe did not play a vital role in vitamin D induced radiosensitivity; moreover, 
vitamin D  in combination with radiation did not appear to increase DNA damage, alter 
DNA repair, or modify the generation of reactive oxygen species. (Demasters et al., 2006; 
DeMasters et al., 2004)    
The current work is consistent with the premise in a number of studies that 
radiation promotes cytoprotective autophagy and that radiation sensitization can be 
mediated through pharmacological or genetic suppression of autophagy. However, our 
studies are also consistent with the conclusion that autophagy is the basis for enhanced 
sensitivity and cell death in response to irradiation when irradiation is preceded by either 
1,25D3 or the vitamin D analog, EB1089; this conclusion is based on evidence for 
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autophagy via multiple assays that include autophagic vesicle formation, RFP-LC3 
redistribution and punctuation, electron microscopy and degradation of the p62 protein, as 
well as lack of evidence for other modes of cell death.  Consequently, in this experimental 
model, it appears that autophagy may have the capacity to play dual roles, both of which 
can be exploited to enhance the response to radiation. 
One evident limitation to confirming the cytotoxic functions of autophagy in this 
experimental system is that neither pharmacological nor genetic inhibition of autophagy 
reduce sensitivity to the combination treatment due to the fact that the irradiated cells die 
by an alternative pathway, that of apoptosis, which is a frequent observation when 
autophagy is blocked in tumor cells exposed to stress. (Amaravadi et al., 2007; Boya et al., 
2005; Gonzalez-Polo et al., 2007) However, in support of our conclusions relating to 
cytotoxic autophagy by the combination treatment of 1,25 D3 + radiation, we have reported 
that in ZR-75 breast tumor cells, a cell line where cytoprotective autophagy is relatively 
weak, the cells are unequivocally protected from the combination treatment by both 
pharmacologic and genetic autophagy inhibition (manuscript accepted upon revision). 
Moreover, cytotoxic autophagy by the combination treatment of 1,25 D3 + radiation can 
also be observed in the Hs578t cells; the lack of p62 degradation with radiation alone in 
Hs578t cells also suggests a lack of cytoprotective autophagy and studies are currently 
being conducted to determine the effects of autophagic inhibition in this system.    
 An additional complication is that p62 degradation in MCF-7 cells is essentially 
identical for the cytoprotective response to radiation alone and the cytotoxic action of the 
1,25D3+ radiation combination treatment.  This may be indicative of the fact that both the 
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cytoprotective autophagy and cytotoxic autophagy are mediated by similar pathways.  
Moreover, 1,25D3’s capacity alone to increase p62 levels may lessen the capacity of the 
combination treatment to completely abrogate p62.  In contrast, only the 1,25D3+ radiation 
combination but not radiation alone promotes p62 degradation in the Hs578t cells, further 
supporting the premise of increased autophagic flux associated with radiosensitization by 
1,25D3.  In this context, it should be noted that there is virtually no information in the 
literature relating to the impact of radiation on p62 stability. As p62 function is not limited 
solely to autophagy but is also associated with ubiquitin mediated protein degradation 
(Pankiv et al., 2007; Ding et al., 2008) it remains possible that our findings may reflect 
alternative and perhaps as yet undefined functions of p62.  
While there is some evidence that EB1089 or 1,25D3 alone can induce 
autophagosome formation and autophagic flux,(Hoyer-Hansen et al., 2005; Hoyer-Hansen 
et al., 2007; Tavera-Mendoza et al., 2006; Wang et al., 2008; Yuk et al., 2009) under the 
experimental conditions of the current studies, no autophagy is observed with EB1089 or 
1,25D3 alone.  Our current studies with EB1089 and 1,25D3 demonstrate comparable 
temporal responses to both agents alone and in combination with irradiation, indicating 
equivalent utilities for both drugs.  We also show that as with EB1089, 1,25D3 suppresses 
the proliferative recovery that occurs after radiation alone.  This component of the response 
to radiation is potentially of clinical significance since the senescence that otherwise occurs 
with radiation alone could prove to reflect tumor dormancy that is ultimately succeeded by 
disease recurrence. (Gewirtz et al., 2009)(Beausejour et al., 2003)  
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Our studies also indicate that sensitization can occur even in cells that are 
intrinsically resistant to radiation through over expression of Her-2/neu. Unexpectedly, 
MCF7HER2 cells were extremely sensitive to the antiproliferative effects of the 1,25D3. 
Conversely, an apparent deficiency of the Vitamin D receptor in the BT474 cells is likely 
to be the explanation for their lack of radiosensitization with vitamin D, and the absence of 
autophagy. Interestingly, Costa et al have suggested that the Vitamin D receptor may be 
unnecessary for its antiproliferative actions, which could indicate that effects on tumor cell 
growth and radiation sensitivity are dissociable. (Costa et al., 2009) With regard to the 
Hs578t cells, we have confirmed the report of radiation resistance and sensitization by 
1,25D3; however, similar to the findings by Mineva et al., (Mineva et al., 2009) the extent 
of sensitization was somewhat lower than for MCF7 cells. This may be related to the fact 
that these cells have mutant p53, as we have reported previously that MCF7/E6 cells (that 
are essentially null for p53) are relatively refractory to sensitization; (Sundaram et al., 
2003) however, other factors such as levels of the metabolic enzymes, 24 hydroxylase and 
alpha hydroxylase may also prove to influence the response.  
Previous studies showed vitamin D did not radiosensitize noncancerous MCF10a 
cells.  (Polar et al., 2003)  Likewise, pharmacological blockade of autophagy did not 
sensitize noncancerous MCF10a cells to radiation suggesting selective radiosensitization 
against cancer cell lines.  Conversely, 4T1 cells, which were not radiosensitized via 
1,25D3, were signifantly responsive to CQ alone or in combination with radiation in vitro.   
In summary, these in vitro studies are consistent with the possibility that both 
cytoprotective and cytotoxic autophagy can occur in breast tumor cells exposed to 
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radiation and furthermore that both forms of autophagy could potentially be exploited for 
the purpose of radiosensitization.   
 
7.2 In vivo data. 
 While in vitro data and previous studies conducted with 4T1 cells in vivo (Jiang et 
al., 2010) indicated that CQ alone sensitizes female BALB/c mice implanted with 4T1 
cells, this was not observed in our animals.  A variety of factors may be involved in these 
differential responses and is discussed below.  4T1 cells rapidly proliferate; palpable 
tumors quickly become necrotic and ulcerated preventing long term observational studies.  
The studies by Jiang et al. injected 1x106 cells s.c. per flank (double the amount of cells 
injected in the studies presented in Chapter 6) and animals were injected with 50mg/kg 
once a day for 28 days, allowing for palpable tumors to reach over 2000mm3, which our 
IACUC protocol will not allow.  Moreover, CQ treatment did not significantly alter tumor 
growth until 37 days post-challenge; rapid ulceration confounds our ability to allow for this 
late a time point.   
 A number of studies have been published indicating chloroquine can enhance the 
response to radiation both in vitro and in vivo.(Chaachouay et al., 2011; Gaudin and 
Yielding, 1969; Jiang et al., 2010; Kim et al., 1973; Livesey et al., 2009; Pazmino and 
Yuhas, 1974; Solomon and Lee, 2009; Zhao et al., 2005)   In contrast, our studies indicate 
that while 4T1 cells were highly responsive to CQ alone or in combination with radiation 
in vitro, CQ did not appear to sensitize 4T1 cells in vivo.  This may be due to a wide 
variety of factors; most notably the pharmacokinetic properties of chloroquine in our 
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system may contribute to this vast disparity.   25µM Chloroquine added in vitro is not 
subject to rapid catabolism; therefore it is likely that a steady state is maintained 
throughout the 72 hour incubation.  However, daily 50mg/kg chloroquine given i.p. is 
subject to absorption, distribution, metabolism, and excretion and may not allow for 
consistent levels to fall within the effective dose range for this system.   
 
7.3 Future studies.  
 The clinical implications and utility and of vitamin D has considerably expanded 
over the last decade.  A number of case studies have suggested that vitamin D deficiency 
can contribute to an increased incidence, recurrence, and mortality rates in relation to 
breast, colorectal, and prostate cancers (Abbas et al., 2008; Bertone-Johnson et al., 2005; 
Goodwin et al., 2009; Lowe et al., 2005; Porojnicu et al., 2007; Porojnicu et al., 2008); 
moreover, vitamin D3, and its analogs, have shown promising efficacy when in used in 
combination with a number of chemotherapeutics(Van Leeuwen and Pols, 2005).  The 
observations implicating the inverse relationship of vitamin D3 levels and cancer needs 
further elucidation into the mechanism behind this and the systemic levels of vitamin D3 
needed for these effects. 
 Primary breast cancers often respond quite well to initial treatment.  Regrettably, a 
subset of patients experience disease recurrence or metastatic spread of the disease 
resulting in an increase in morbidity and mortality.  The impact of current and future 
studies lies in the prospect that vitamin D3 in combination with radio- or chemotherapy, 
may prevent proliferative recovery and disease recurrence.  Furthermore, vitamin D3 may 
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serve to sensitize cancers that might not be as initially responsive to treatment; our 
laboratory has now expanded vitamin D3 combinational studies to include lung, pancreatic, 
ovarian cancers. 
 While vitamin D3 clearly radiosensitizes breast tumor cells through autophagy, the 
mechanism by which has still yet to be elucidated.  In several breast cancer cell lines, 
1,25D3 can decrease bcl-2 expression (Van Leeuwen and Pols, 2005).  The dissociation of 
beclin-1 from bcl-2 is essential for its autophagic activity; additionally bcl-2 only inhibits 
autophagy when it is present in the endoplasmic reticulum (ER) (Maiuri et al., 2010).  
Current studies suggest that an increased incidence of ER stress is observed with 1,25D3 
and radiation in comparison to radiation alone.  It is therefore possible that 1,25D3’s ability 
to reduce bcl-2 expression, allows for the uncoupling of beclin-1, which may prime breast 
tumor cells for ER stress-induced autophagy upon additional insult.  Additional studies are 
currently being conducted to further clarify these pathways.   
 Complementary to our 1,25D3 studies, our data also indicates CQ may have 
radiosensitizing properties.  This may be of particular use in tumor cell lines which utilize 
autophagy as a protective mechanism, and in those lacking the vitamin D receptor.  
Moreover, CQ is already FDA approved for the treatment of malaria and is readily 
available for use in the clinic.  Additionally, because of minimal toxicities with use, CQ 
may have greater clinical utility than 1,25D3.  With these indications, our data has led to 
the initiation of a phase I clinical trial that will utilize CQ in combination with 
radiotherapeutics in all cancer subtypes.   
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7.4 Additional Points. 
Though autophagy appeared to play a role in 1,25D3 radiosensitization of Hs578t 
cells breast tumor cells, apoptosis was also found to be significantly increased with the 
combination.  Additionally, the level of radiosensitization observed in Hs578t cells was not 
as dramatic as observed with MCF7 cells.  While a variety of factors may contribute to this 
differential response, it may be due in part to the mutant status of p53 in the Hs578t cells.  
Previous data in our laboratory found that in MCF7/E6 cells, with attenuated p53 function, 
there was no detectable difference in viability with radiation alone or in combination with 
EB1089 (DeMasters et al. 2006).  Correspondingly, 4T1 cells that are null in p53 
responded like MCF7/E6 cells in that there was no detectable difference in viability with 
radiation alone or in combination with 1,25D3; suggesting p53 functionality plays a role in 
the sensitizing effects of vitamin D in response to radiation.   
 While it was our expectation that inhibition of autophagy in ZR-75 cells with 
functional caspase 3 would induce apoptosis, similar to the observation in MCF7 cells, 
these cells appear to be relatively refractory to apoptosis.  In support of our conclusions 
relating to cytotoxic autophagy by the combination treatment of 1,25 D3 + radiation, data 
developed by Eden Wilson indicates that in ZR-75 breast tumor cells, a cell line where 
cytoprotective autophagy is relatively weak, the cells are unequivocally protected from the 
combination treatment by both pharmacologic and genetic autophagy inhibition 
(manuscript accepted upon revision). Additionally, utilizing a lower dose of CQ in 
combination with a single dose of 4 Gy IR in MCF7 cells, Wilson et al. was able to reduce 
blockade of cytoprotective autophagy.  Employing this treatment paradigm, 
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pharmacological inhibition of autophagy in MCF7 cells treated with radiation combination 
with 1,25D3, allowed for recovery of proliferative capacity.  This data further supports our 
contention that autophagy is the main mode of cell death induced by vitamin D 
radiosensitization.   
Controversy in the current literature debates whether autophagy can be both 
cytoprotective or cytotoxic.  Moreover, it is currently not well understood as to what may 
be involved in the autophagic transformation between death and survival (Klionsky et al., 
2008; Mizushima et al., 1998; Mizushima and Klionsky, 2007; Mizushima et al., 2008).  
Our laboratory’s current strategy is to determine the differences between cytoprotective 
and cytotoxic autophagy.  Studies will utilize mass spectrometry to determine if there are 
any observable alterations in protein levels between radiation in the presence or absence of 
1,25D3.  Moreover, gene arrays are currently being analyzed to elucidate alterations in 
gene expression between 1,25D3, radiation, and the combination.   
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